| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | structural constituent of nuclear pore | 3.39e-07 | 25 | 232 | 6 | GO:0017056 | |
| GeneOntologyMolecularFunction | signal sequence binding | 1.96e-06 | 51 | 232 | 7 | GO:0005048 | |
| GeneOntologyMolecularFunction | nuclear localization sequence binding | 1.33e-05 | 27 | 232 | 5 | GO:0008139 | |
| GeneOntologyMolecularFunction | nuclear receptor binding | HIF1A BRD8 PRAMEF11 PRAMEF15 TACC2 PRAMEF4 JMJD1C CNOT1 PRAMEF27 SMAD3 | 6.94e-05 | 187 | 232 | 10 | GO:0016922 |
| GeneOntologyMolecularFunction | RNA polymerase II-specific DNA-binding transcription factor binding | SP100 HIF1A ACTB BBS1 STING1 BRD8 PRAMEF11 PRAMEF15 TACC2 PRAMEF4 ATF2 JMJD1C CNOT1 PRAMEF27 SMAD3 | 1.16e-04 | 417 | 232 | 15 | GO:0061629 |
| GeneOntologyMolecularFunction | kinase binding | NRG1 SP100 HIF1A MAPT PSG6 ACTBL2 ACTA2 ACTB ACTG1 STING1 PFKFB2 RB1CC1 PARP6 AP2A2 DLG2 BCAR3 FERMT2 SFN PPP1R9A DNM1L ATF2 STRIP1 IFNAR2 GOLGA8B SMAD3 | 1.65e-04 | 969 | 232 | 25 | GO:0019900 |
| GeneOntologyMolecularFunction | structural constituent of postsynaptic actin cytoskeleton | 2.38e-04 | 11 | 232 | 3 | GO:0098973 | |
| GeneOntologyMolecularFunction | GTPase binding | TSC2 RABGAP1 SH3BP4 AFDN NUP153 UNC13B DMXL2 RNF152 PPP1R9A DNM1L CDC42EP3 STRIP1 DGKI | 3.18e-04 | 360 | 232 | 13 | GO:0051020 |
| GeneOntologyMolecularFunction | small GTPase binding | TSC2 RABGAP1 SH3BP4 AFDN NUP153 UNC13B DMXL2 RNF152 DNM1L CDC42EP3 STRIP1 DGKI | 3.96e-04 | 321 | 232 | 12 | GO:0031267 |
| GeneOntologyMolecularFunction | nuclear retinoic acid receptor binding | 4.40e-04 | 55 | 232 | 5 | GO:0042974 | |
| GeneOntologyMolecularFunction | DNA-binding transcription factor binding | TCP10L SP100 HIF1A ACTB BBS1 STING1 BRD8 PRAMEF11 PRAMEF15 TACC2 PRAMEF4 RFC1 ATF2 JMJD1C CNOT1 PRAMEF27 SMAD3 | 4.84e-04 | 582 | 232 | 17 | GO:0140297 |
| GeneOntologyMolecularFunction | structural constituent of postsynapse | 4.95e-04 | 32 | 232 | 4 | GO:0099186 | |
| GeneOntologyMolecularFunction | transcription factor binding | TCP10L SP100 HIF1A NACA ACTB BBS1 STING1 BRD8 PRAMEF11 PRAMEF15 TACC2 BTAF1 PRAMEF4 RFC1 ATF2 JMJD1C TAF3 CNOT1 PRAMEF27 SMAD3 | 5.26e-04 | 753 | 232 | 20 | GO:0008134 |
| GeneOntologyMolecularFunction | protein kinase binding | NRG1 HIF1A MAPT PSG6 ACTBL2 ACTA2 ACTB ACTG1 STING1 PFKFB2 RB1CC1 AP2A2 DLG2 FERMT2 SFN PPP1R9A DNM1L ATF2 STRIP1 IFNAR2 GOLGA8B SMAD3 | 5.64e-04 | 873 | 232 | 22 | GO:0019901 |
| GeneOntologyMolecularFunction | ErbB-2 class receptor binding | 7.94e-04 | 4 | 232 | 2 | GO:0005176 | |
| GeneOntologyMolecularFunction | structural constituent of cytoskeleton | 8.23e-04 | 130 | 232 | 7 | GO:0005200 | |
| GeneOntologyMolecularFunction | enzyme-substrate adaptor activity | 8.47e-04 | 95 | 232 | 6 | GO:0140767 | |
| GeneOntologyMolecularFunction | protein-macromolecule adaptor activity | TCP10L NRG1 HIP1 PRAMEF9 MAPT NACA GON4L STING1 RB1CC1 TDRD3 BRD8 AP2A2 TOX3 NUP153 PRAMEF11 A1CF PRAMEF15 BTAF1 PRAMEF4 MED13L JMJD1C STRIP1 IFNAR2 KDM7A MAML2 PRAMEF27 | 1.03e-03 | 1160 | 232 | 26 | GO:0030674 |
| GeneOntologyMolecularFunction | structural constituent of synapse | 1.41e-03 | 42 | 232 | 4 | GO:0098918 | |
| GeneOntologyMolecularFunction | transferase activity, transferring phosphorus-containing groups | SMG1 CDK18 DAPK2 DAPK1 PFKFB2 PXK PARP6 STK10 BMX BUB1B DLG2 PIGO STK25 CDC42BPG TUT4 AAK1 REV3L POLR3A NUAK2 ITPKC DGKI POLQ | 1.43e-03 | 938 | 232 | 22 | GO:0016772 |
| GeneOntologyBiologicalProcess | protein localization to organelle | SP100 MAPT NACA DAG1 BBS1 TOMM20 TSC2 STING1 PXK ASAP1 SH3BP4 CEP350 POM121 TOMM40L BUB1B CIZ1 DLG2 FERMT2 AP3D1 NUP153 MMS22L NUP107 DNM1L NUP214 TEX15 POM121C ATF2 NUAK2 TAF3 MACF1 ZW10 POM121B SMAD3 DNAH11 | 5.55e-08 | 1091 | 230 | 34 | GO:0033365 |
| GeneOntologyBiologicalProcess | mesenchyme migration | 7.47e-08 | 5 | 230 | 4 | GO:0090131 | |
| GeneOntologyBiologicalProcess | nuclear pore organization | 1.26e-06 | 18 | 230 | 5 | GO:0006999 | |
| GeneOntologyBiologicalProcess | nuclear export | SMG1 SP100 POM121 RAPGEF3 NUP153 SFN NUP107 NUP214 POM121C POM121B | 4.51e-05 | 185 | 230 | 10 | GO:0051168 |
| GeneOntologyBiologicalProcess | protein localization to nucleus | SP100 TSC2 POM121 CIZ1 FERMT2 NUP153 NUP107 NUP214 POM121C ATF2 NUAK2 TAF3 POM121B SMAD3 | 5.97e-05 | 362 | 230 | 14 | GO:0034504 |
| GeneOntologyBiologicalProcess | regulation of transforming growth factor beta2 production | 7.35e-05 | 8 | 230 | 3 | GO:0032909 | |
| GeneOntologyBiologicalProcess | transforming growth factor beta2 production | 7.35e-05 | 8 | 230 | 3 | GO:0032906 | |
| GeneOntologyBiologicalProcess | RNA export from nucleus | 1.01e-04 | 96 | 230 | 7 | GO:0006405 | |
| GeneOntologyBiologicalProcess | adherens junction maintenance | 1.09e-04 | 9 | 230 | 3 | GO:0034334 | |
| GeneOntologyBiologicalProcess | synaptic vesicle recycling via endosome | 1.55e-04 | 10 | 230 | 3 | GO:0036466 | |
| GeneOntologyBiologicalProcess | RNA transport | SMG1 MAPT TOMM20 POM121 NUP153 NUP107 NUP214 POM121C POM121B | 1.58e-04 | 175 | 230 | 9 | GO:0050658 |
| GeneOntologyBiologicalProcess | nucleic acid transport | SMG1 MAPT TOMM20 POM121 NUP153 NUP107 NUP214 POM121C POM121B | 1.58e-04 | 175 | 230 | 9 | GO:0050657 |
| GeneOntologyBiologicalProcess | RNA localization | SMG1 MAPT TOMM20 POM121 NUP153 A1CF NUP107 NUP214 POM121C POM121B | 1.70e-04 | 217 | 230 | 10 | GO:0006403 |
| GeneOntologyBiologicalProcess | establishment of RNA localization | SMG1 MAPT TOMM20 POM121 NUP153 NUP107 NUP214 POM121C POM121B | 1.80e-04 | 178 | 230 | 9 | GO:0051236 |
| GeneOntologyBiologicalProcess | regulation of stress fiber assembly | 1.98e-04 | 107 | 230 | 7 | GO:0051492 | |
| GeneOntologyCellularComponent | actin cytoskeleton | HIP1 ACTBL2 RGS22 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 DAPK1 ASAP1 RAPGEF3 AHNAK FERMT2 PPP1R9A CDC42EP3 ACTR2 MACF1 LSP1 HSPB7 | 5.61e-06 | 576 | 228 | 20 | GO:0015629 |
| GeneOntologyCellularComponent | cell leading edge | MAPT INPP5K ACTA1 ACTA2 ACTB DAG1 ACTC1 ACTG2 BMX ARHGAP31 RAPGEF3 FERMT2 CDC42BPG PPP1R9A AAK1 ACTR2 MACF1 | 3.76e-05 | 500 | 228 | 17 | GO:0031252 |
| GeneOntologyCellularComponent | lamellipodium | ACTA1 ACTA2 ACTB DAG1 ACTC1 ACTG2 ARHGAP31 RAPGEF3 FERMT2 PPP1R9A ACTR2 | 4.73e-05 | 230 | 228 | 11 | GO:0030027 |
| GeneOntologyCellularComponent | H4 histone acetyltransferase complex | 1.26e-04 | 45 | 228 | 5 | GO:1902562 | |
| GeneOntologyCellularComponent | Cul2-RING ubiquitin ligase complex | 1.56e-04 | 47 | 228 | 5 | GO:0031462 | |
| GeneOntologyCellularComponent | NuA4 histone acetyltransferase complex | 3.90e-04 | 32 | 228 | 4 | GO:0035267 | |
| GeneOntologyCellularComponent | H4/H2A histone acetyltransferase complex | 3.90e-04 | 32 | 228 | 4 | GO:0043189 | |
| GeneOntologyCellularComponent | filopodium | 4.08e-04 | 123 | 228 | 7 | GO:0030175 | |
| GeneOntologyCellularComponent | nuclear protein-containing complex | SP100 HIF1A ACTB GON4L DHX8 TDRD3 BRD8 POM121 BUB1B ASCC2 AFF1 NUP153 INTS6L MMS22L A1CF NUP107 ICE2 CAMSAP3 NUP214 MED13L POM121C RFX5 ATF2 JMJD1C POLR3A TAF3 GTF2H4 POM121B SMAD3 | 5.12e-04 | 1377 | 228 | 29 | GO:0140513 |
| GeneOntologyCellularComponent | motile cilium | HIF1A ACTA2 BBS1 TOMM20 FSCB PRAMEF11 CFAP47 PRAMEF15 CAMSAP3 PRAMEF4 TTC29 DNAH11 | 5.55e-04 | 355 | 228 | 12 | GO:0031514 |
| GeneOntologyCellularComponent | histone acetyltransferase complex | 5.77e-04 | 94 | 228 | 6 | GO:0000123 | |
| GeneOntologyCellularComponent | calyx of Held | 6.17e-04 | 36 | 228 | 4 | GO:0044305 | |
| GeneOntologyCellularComponent | cytoplasmic region | HIF1A MAPT ODAD1 BBS1 BLOC1S1 ADA DLG2 AP3D1 UNC13B CAMSAP3 CFAP46 DNAH11 | 6.27e-04 | 360 | 228 | 12 | GO:0099568 |
| GeneOntologyCellularComponent | plasma membrane bounded cell projection cytoplasm | HIF1A MAPT ODAD1 BBS1 BLOC1S1 ADA DLG2 AP3D1 CAMSAP3 CFAP46 DNAH11 | 7.57e-04 | 317 | 228 | 11 | GO:0032838 |
| GeneOntologyCellularComponent | nuclear pore | 8.44e-04 | 101 | 228 | 6 | GO:0005643 | |
| GeneOntologyCellularComponent | axon cytoplasm | 8.81e-04 | 68 | 228 | 5 | GO:1904115 | |
| GeneOntologyCellularComponent | transferase complex | BRPF3 PRAMEF9 PSG6 ACTBL2 ACTB ACTG1 DAPK1 STING1 RB1CC1 BRD8 BUB1B PRAMEF11 AMN1 PRAMEF15 PRAMEF4 REV3L ATF2 VIRMA POLR3A TAF3 GTF2H4 PRAMEF27 | 8.91e-04 | 963 | 228 | 22 | GO:1990234 |
| GeneOntologyCellularComponent | protein acetyltransferase complex | 9.83e-04 | 104 | 228 | 6 | GO:0031248 | |
| GeneOntologyCellularComponent | blood microparticle | 1.04e-03 | 144 | 228 | 7 | GO:0072562 | |
| GeneOntologyCellularComponent | postsynaptic actin cytoskeleton | 1.09e-03 | 19 | 228 | 3 | GO:0098871 | |
| GeneOntologyCellularComponent | acetyltransferase complex | 1.25e-03 | 109 | 228 | 6 | GO:1902493 | |
| GeneOntologyCellularComponent | neuron projection cytoplasm | 1.31e-03 | 110 | 228 | 6 | GO:0120111 | |
| GeneOntologyCellularComponent | costamere | 1.69e-03 | 22 | 228 | 3 | GO:0043034 | |
| GeneOntologyCellularComponent | axon | NRG1 GRIPAP1 HIF1A MAPT ACTBL2 ACTB DAG1 ACTG1 TSC2 BLOC1S1 RAPGEF3 SCN4A SCN8A DLG2 AFDN AP3D1 UNC13B PPP1R9A AAK1 DGKI | 1.87e-03 | 891 | 228 | 20 | GO:0030424 |
| GeneOntologyCellularComponent | nuclear body | SP100 HIF1A HIVEP1 MAPT GON4L ERBIN DHX8 GARIN3 ASCC2 PLAG1 AFDN ICE2 VIRMA ZNF106 ITPKC GTF2H4 SETBP1 MAML2 HSPB7 SON | 2.19e-03 | 903 | 228 | 20 | GO:0016604 |
| GeneOntologyCellularComponent | intracellular protein-containing complex | BRPF3 PRAMEF9 ACTBL2 ACTB ACTG1 BLOC1S1 BRD8 EIF2B3 BUB1B PRAMEF11 AMN1 PRAMEF15 PRAMEF4 REV3L ATF2 POLR3A TAF3 GTF2H4 DGKI CNOT1 PRAMEF27 | 2.29e-03 | 972 | 228 | 21 | GO:0140535 |
| GeneOntologyCellularComponent | adherens junction | 2.34e-03 | 212 | 228 | 8 | GO:0005912 | |
| GeneOntologyCellularComponent | dense body | 2.40e-03 | 7 | 228 | 2 | GO:0097433 | |
| GeneOntologyCellularComponent | postsynaptic cytoskeleton | 2.77e-03 | 26 | 228 | 3 | GO:0099571 | |
| GeneOntologyCellularComponent | nuclear periphery | 2.77e-03 | 171 | 228 | 7 | GO:0034399 | |
| GeneOntologyCellularComponent | nuclear speck | HIF1A MAPT ERBIN ASCC2 PLAG1 AFDN VIRMA ZNF106 ITPKC GTF2H4 MAML2 SON | 2.86e-03 | 431 | 228 | 12 | GO:0016607 |
| Domain | ACTINS_1 | 2.74e-13 | 8 | 226 | 7 | PS00406 | |
| Domain | Actin/actin-like_CS | 1.60e-11 | 18 | 226 | 8 | IPR020902 | |
| Domain | ACTINS_ACT_LIKE | 2.74e-11 | 19 | 226 | 8 | PS01132 | |
| Domain | Actin_CS | 3.61e-10 | 16 | 226 | 7 | IPR004001 | |
| Domain | ACTINS_2 | 6.07e-10 | 17 | 226 | 7 | PS00432 | |
| Domain | Actin | 2.52e-09 | 31 | 226 | 8 | IPR004000 | |
| Domain | Actin | 2.52e-09 | 31 | 226 | 8 | PF00022 | |
| Domain | ACTIN | 2.52e-09 | 31 | 226 | 8 | SM00268 | |
| Domain | PRAME_family | 7.02e-05 | 19 | 226 | 4 | IPR026271 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 4.52e-06 | 40 | 155 | 6 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 5.25e-06 | 41 | 155 | 6 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 6.07e-06 | 42 | 155 | 6 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 6.99e-06 | 43 | 155 | 6 | MM14609 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 1.19e-05 | 47 | 155 | 6 | MM14939 | |
| Pathway | WP_MECHANOREGULATION_AND_PATHOLOGY_OF_YAPTAZ_VIA_HIPPO_AND_NONHIPPO_MECHANISMS | 1.19e-05 | 47 | 155 | 6 | M39829 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ANXA2_S100A10_REGULATED_ACTIN_CYTOSKELETON | 1.28e-05 | 5 | 155 | 3 | M49034 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 1.52e-05 | 49 | 155 | 6 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 1.71e-05 | 50 | 155 | 6 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 1.92e-05 | 51 | 155 | 6 | MM15151 | |
| Pathway | REACTOME_REGULATION_OF_GLUCOKINASE_BY_GLUCOKINASE_REGULATORY_PROTEIN | 2.39e-05 | 32 | 155 | 5 | M29579 | |
| Pathway | REACTOME_EXPORT_OF_VIRAL_RIBONUCLEOPROTEINS_FROM_NUCLEUS | 2.79e-05 | 33 | 155 | 5 | M27016 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 2.98e-05 | 55 | 155 | 6 | MM14917 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 3.23e-05 | 82 | 155 | 7 | MM15394 | |
| Pathway | REACTOME_NUCLEAR_IMPORT_OF_REV_PROTEIN | 3.24e-05 | 34 | 155 | 5 | M27041 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 3.75e-05 | 35 | 155 | 5 | M27320 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 3.78e-05 | 84 | 155 | 7 | MM14929 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 4.05e-05 | 58 | 155 | 6 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 4.05e-05 | 58 | 155 | 6 | MM14736 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 4.31e-05 | 36 | 155 | 5 | M26974 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 4.31e-05 | 36 | 155 | 5 | M27245 | |
| Pathway | REACTOME_INTERACTIONS_OF_REV_WITH_HOST_CELLULAR_PROTEINS | 4.94e-05 | 37 | 155 | 5 | M27038 | |
| Pathway | REACTOME_INTERACTIONS_OF_VPR_WITH_HOST_CELLULAR_PROTEINS | 4.94e-05 | 37 | 155 | 5 | M1029 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 6.41e-05 | 39 | 155 | 5 | M27238 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 7.76e-05 | 65 | 155 | 6 | MM15147 | |
| Pathway | REACTOME_NS1_MEDIATED_EFFECTS_ON_HOST_PATHWAYS | 8.20e-05 | 41 | 155 | 5 | M29574 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 1.04e-04 | 43 | 155 | 5 | M26975 | |
| Pathway | REACTOME_VIRAL_MESSENGER_RNA_SYNTHESIS | 1.16e-04 | 44 | 155 | 5 | M109 | |
| Pathway | REACTOME_POSTMITOTIC_NUCLEAR_PORE_COMPLEX_NPC_REFORMATION | 1.26e-04 | 24 | 155 | 4 | MM15658 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 1.44e-04 | 46 | 155 | 5 | M27397 | |
| Pathway | KEGG_MEDICUS_VARIANT_DELETED_DMD_TO_DYSTROPHIN_ASSOCIATED_PROTEIN_COMPLEX | 1.48e-04 | 10 | 155 | 3 | M47575 | |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 1.49e-04 | 73 | 155 | 6 | MM14948 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 1.59e-04 | 47 | 155 | 5 | M27395 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 2.00e-04 | 77 | 155 | 6 | M27226 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 2.61e-04 | 114 | 155 | 7 | MM15361 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | ARHGAP24 ACTB ACTC1 ACTG1 ERBIN STK10 ARHGAP31 BUB1B FERMT2 SFN NUP107 CDC42EP3 ACTR2 UBXN11 PLEKHG6 RHPN2 GOLGA8B ZW10 | 2.79e-04 | 649 | 155 | 18 | MM15690 |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 2.83e-04 | 53 | 155 | 5 | M27212 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 3.09e-04 | 54 | 155 | 5 | M29594 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 3.43e-04 | 85 | 155 | 6 | M1870 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPAC_TO_ACTIN_SIGNALING_PATHWAY | 3.44e-04 | 13 | 155 | 3 | M47723 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_MAP_TO_CDC42_SIGNALING_PATHWAY | 3.44e-04 | 13 | 155 | 3 | M47730 | |
| Pathway | REACTOME_INTERACTION_BETWEEN_L1_AND_ANKYRINS | 3.51e-04 | 31 | 155 | 4 | M877 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 3.65e-04 | 86 | 155 | 6 | MM15413 | |
| Pathway | REACTOME_SARS_COV_2_HOST_INTERACTIONS | 4.25e-04 | 204 | 155 | 9 | M45011 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_EAE_TIR_TCCP_TO_ACTIN_SIGNALING_PATHWAY | 4.34e-04 | 14 | 155 | 3 | M47729 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_ESPT_TO_RAC_SIGNALING_PATHWAY | 4.34e-04 | 14 | 155 | 3 | M47726 | |
| Pathway | REACTOME_TRNA_PROCESSING_IN_THE_NUCLEUS | 4.67e-04 | 59 | 155 | 5 | M27606 | |
| Pathway | REACTOME_SARS_COV_2_ACTIVATES_MODULATES_INNATE_AND_ADAPTIVE_IMMUNE_RESPONSES | 4.80e-04 | 126 | 155 | 7 | M45009 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 5.25e-04 | 92 | 155 | 6 | MM14951 | |
| Pathway | PID_SMAD2_3PATHWAY | 6.57e-04 | 16 | 155 | 3 | M228 | |
| Pathway | WP_STRIATED_MUSCLE_CONTRACTION_PATHWAY | 7.76e-04 | 38 | 155 | 4 | M39549 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_ESCHERICHIA_EAE_TIR_TO_ACTIN_SIGNALING_PATHWAY | 7.92e-04 | 17 | 155 | 3 | M47728 | |
| Pathway | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | 9.42e-04 | 18 | 155 | 3 | M840 | |
| Pathway | REACTOME_CELL_EXTRACELLULAR_MATRIX_INTERACTIONS | 9.42e-04 | 18 | 155 | 3 | MM15123 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | ARHGAP24 ACTB ACTC1 ACTG1 ERBIN SHKBP1 STK10 ARHGAP31 BUB1B FERMT2 SFN NUP107 CDC42EP3 ACTR2 UBXN11 PLEKHG6 RHPN2 ZW10 | 9.46e-04 | 720 | 155 | 18 | M41838 |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 9.77e-04 | 142 | 155 | 7 | MM15576 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 1.09e-03 | 71 | 155 | 5 | M27394 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | ARHGAP24 ACTB ACTC1 ACTG1 ERBIN STK10 ARHGAP31 FERMT2 CDC42EP3 UBXN11 PLEKHG6 RHPN2 GOLGA8B | 1.12e-03 | 439 | 155 | 13 | MM15595 |
| Pathway | REACTOME_RHOA_GTPASE_CYCLE | 1.29e-03 | 149 | 155 | 7 | M41805 | |
| Pathway | REACTOME_HIV_LIFE_CYCLE | 1.29e-03 | 149 | 155 | 7 | M4076 | |
| Pathway | REACTOME_NOTCH4_INTRACELLULAR_DOMAIN_REGULATES_TRANSCRIPTION | 1.30e-03 | 20 | 155 | 3 | M27881 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPE_TO_RAC_SIGNALING_PATHWAY | 1.30e-03 | 20 | 155 | 3 | M47737 | |
| Pathway | REACTOME_ISG15_ANTIVIRAL_MECHANISM | 1.32e-03 | 74 | 155 | 5 | M48006 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | ARHGAP24 ACTB ACTC1 ACTG1 ERBIN SHKBP1 STK10 ARHGAP31 FERMT2 CDC42EP3 UBXN11 PLEKHG6 RHPN2 | 1.40e-03 | 450 | 155 | 13 | M27078 |
| Pathway | REACTOME_TRNA_PROCESSING | 1.41e-03 | 111 | 155 | 6 | M27684 | |
| Pathway | KEGG_MEDICUS_REFERENCE_EGF_EGFR_ACTIN_SIGNALING_PATHWAY | 1.50e-03 | 21 | 155 | 3 | M47722 | |
| Pathway | PID_P38_MK2_PATHWAY | 1.50e-03 | 21 | 155 | 3 | M199 | |
| Pathway | WP_MYOMETRIAL_RELAXATION_AND_CONTRACTION_PATHWAYS | 1.68e-03 | 156 | 155 | 7 | M39475 | |
| Pathway | REACTOME_SARS_COV_2_INFECTION | STING1 TUFM PARP6 POM121 NUP153 SFN NUP107 NUP214 POM121C IFNAR2 | 1.74e-03 | 299 | 155 | 10 | M41727 |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 2.08e-03 | 82 | 155 | 5 | M27250 | |
| Pubmed | Virus assembly and plasma membrane domains: which came first? | 9.64e-14 | 6 | 238 | 6 | 22989508 | |
| Pubmed | 9.64e-14 | 6 | 238 | 6 | 12009869 | ||
| Pubmed | HIV-1 Tat protein variants: critical role for the cysteine region in synaptodendritic injury. | 9.64e-14 | 6 | 238 | 6 | 23811015 | |
| Pubmed | Retroviral assembly and budding occur through an actin-driven mechanism. | 9.64e-14 | 6 | 238 | 6 | 19883584 | |
| Pubmed | Dynamic imaging of cell-free and cell-associated viral capture in mature dendritic cells. | 9.64e-14 | 6 | 238 | 6 | 21917091 | |
| Pubmed | HIV-1 Gag protein associates with F-actin present in microfilaments. | 9.64e-14 | 6 | 238 | 6 | 8661406 | |
| Pubmed | 9.64e-14 | 6 | 238 | 6 | 23017337 | ||
| Pubmed | 9.64e-14 | 6 | 238 | 6 | 9841925 | ||
| Pubmed | Actin associates with the nucleocapsid domain of the human immunodeficiency virus Gag polyprotein. | 9.64e-14 | 6 | 238 | 6 | 9971772 | |
| Pubmed | Interaction of the human immunodeficiency virus type 1 nucleocapsid with actin. | 9.64e-14 | 6 | 238 | 6 | 10074138 | |
| Pubmed | HIV-1 protease cleaves actin during acute infection of human T-lymphocytes. | 9.64e-14 | 6 | 238 | 6 | 1540415 | |
| Pubmed | HIV type 1 Gag and nucleocapsid proteins: cytoskeletal localization and effects on cell motility. | 9.64e-14 | 6 | 238 | 6 | 11709093 | |
| Pubmed | 9.64e-14 | 6 | 238 | 6 | 10049817 | ||
| Pubmed | Synaptodendritic recovery following HIV Tat exposure: neurorestoration by phytoestrogens. | 9.64e-14 | 6 | 238 | 6 | 23875777 | |
| Pubmed | 6.71e-13 | 7 | 238 | 6 | 22535526 | ||
| Pubmed | HIV-1 replication from after cell entry to the nuclear periphery. | 6.71e-13 | 7 | 238 | 6 | 17504171 | |
| Pubmed | Selective targeting of ITK blocks multiple steps of HIV replication. | 6.71e-13 | 7 | 238 | 6 | 18443296 | |
| Pubmed | The trinity of the cortical actin in the initiation of HIV-1 infection. | 6.71e-13 | 7 | 238 | 6 | 22640593 | |
| Pubmed | 6.71e-13 | 7 | 238 | 6 | 22465675 | ||
| Pubmed | 2.67e-12 | 8 | 238 | 6 | 20147394 | ||
| Pubmed | 2.67e-12 | 8 | 238 | 6 | 23260110 | ||
| Pubmed | 2.67e-12 | 8 | 238 | 6 | 14694110 | ||
| Pubmed | Functional interaction between the cytoplasmic leucine-zipper domain of HIV-1 gp41 and p115-RhoGEF. | 7.96e-12 | 9 | 238 | 6 | 10556093 | |
| Pubmed | Cytoskeletal proteins inside human immunodeficiency virus type 1 virions. | 7.96e-12 | 9 | 238 | 6 | 8892894 | |
| Pubmed | 7.96e-12 | 9 | 238 | 6 | 18775311 | ||
| Pubmed | 1.98e-11 | 10 | 238 | 6 | 1907279 | ||
| Pubmed | Non-viral cellular substrates for human immunodeficiency virus type 1 protease. | 1.98e-11 | 10 | 238 | 6 | 1991513 | |
| Pubmed | 1.98e-11 | 10 | 238 | 6 | 23575248 | ||
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | ZHX3 CHAF1B HIVEP1 MAPT ERBIN EMSY STK10 BRD8 USP42 AFF1 AFDN NUP153 RALGAPB CAMSAP3 AAK1 BTAF1 NUP214 IQCN RFC1 ATF2 VIRMA STRIP1 ZNF106 MYOF TAF3 SON | 3.13e-11 | 774 | 238 | 26 | 15302935 |
| Pubmed | 4.33e-11 | 11 | 238 | 6 | 30962377 | ||
| Pubmed | N-terminal Slit2 inhibits HIV-1 replication by regulating the actin cytoskeleton. | 4.33e-11 | 11 | 238 | 6 | 23294842 | |
| Pubmed | Quantitative proteomic analysis of lentiviral vectors using 2-DE. | 4.33e-11 | 11 | 238 | 6 | 19639585 | |
| Pubmed | 8.61e-11 | 12 | 238 | 6 | 23071112 | ||
| Pubmed | Essential and supporting host cell factors for HIV-1 budding. | 1.44e-10 | 23 | 238 | 7 | 22004035 | |
| Pubmed | 2.77e-10 | 14 | 238 | 6 | 21923909 | ||
| Pubmed | 2.77e-10 | 14 | 238 | 6 | 17411366 | ||
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | CDK18 HIVEP1 MAPT DAPK2 TSC2 PFKFB2 ERBIN SH3BP4 SHKBP1 CEP350 PTPN3 BMX AHNAK BUB1B AFDN SFN RALGAPB CAMSAP3 AAK1 DNM1L VIRMA NUAK2 NHSL1 ZNF106 CEP112 MACF1 | 3.10e-10 | 861 | 238 | 26 | 36931259 |
| Pubmed | 1.12e-09 | 17 | 238 | 6 | 17360745 | ||
| Pubmed | 1.12e-09 | 17 | 238 | 6 | 8997639 | ||
| Pubmed | 1.67e-09 | 18 | 238 | 6 | 24840128 | ||
| Pubmed | The proline-rich domain of tau plays a role in interactions with actin. | 2.14e-09 | 4 | 238 | 4 | 19895707 | |
| Pubmed | BRPF3 ATXN7L1 ERBIN ASAP1 KIAA1210 ARHGAP31 PPP1R9A RALGAPB MYOF MACF1 | 2.52e-09 | 103 | 238 | 10 | 10574462 | |
| Pubmed | ZHX3 GON4L ERBIN ASAP1 FOCAD UNC13B LRCH2 PPP1R9A RALGAPB NUP214 MED13L VIRMA STRIP1 GPCPD1 MACF1 SON PDZD2 | 3.90e-09 | 407 | 238 | 17 | 12693553 | |
| Pubmed | GRIPAP1 ACTBL2 NACA ACTB RB1CC1 EMSY TUFM AHNAK SFN STK25 NUP107 PPP1R9A AAK1 BTAF1 CDC42EP3 MACF1 | 4.72e-09 | 360 | 238 | 16 | 33111431 | |
| Pubmed | Modifications in the human T cell proteome induced by intracellular HIV-1 Tat protein expression. | 6.56e-09 | 22 | 238 | 6 | 16526095 | |
| Pubmed | An improved smaller biotin ligase for BioID proximity labeling. | ACTC1 EMSY TOX3 NUP153 NUP107 NUP214 POM121C JMJD1C CNOT1 PDZD2 | 1.42e-08 | 123 | 238 | 10 | 26912792 |
| Pubmed | ARHGAP24 ACTB DAPK1 TSC2 ERBIN EMSY TDRD3 AP2A2 DLG2 AFDN NUP153 DMXL2 LRCH2 PPP1R9A CAMSAP3 AAK1 MSANTD2 DNM1L VIRMA STRIP1 GOLGA8B DGKI MACF1 EML1 CNOT1 | 1.43e-08 | 963 | 238 | 25 | 28671696 | |
| Pubmed | 1.98e-08 | 26 | 238 | 6 | 24742657 | ||
| Pubmed | 4.09e-08 | 15 | 238 | 5 | 14697343 | ||
| Pubmed | SP100 HIVEP1 ERBIN ASAP1 SH3BP4 CEP350 RTKN2 PTPN3 POM121 ARHGAP31 NUP153 INTS6L NUP214 POM121C CDC42EP3 ZNF106 MACF1 | 5.22e-08 | 486 | 238 | 17 | 20936779 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | INPP5K ASAP1 SH3BP4 STK10 PRR14 POM121 ARHGAP31 AFF1 NUP153 SFN NUP214 POM121C ZNF532 SETBP1 MAML2 SON | 5.61e-08 | 430 | 238 | 16 | 35044719 |
| Pubmed | MAPT ACTBL2 ACTA1 ACTB ACTG1 DAPK1 ERBIN TUFM ASAP1 AP2A2 WASHC5 DLG2 AFDN FERMT2 AP3D1 DMXL2 LRCH2 PPP1R9A CAMSAP3 AAK1 DNM1L VIRMA ACTR2 STRIP1 NUAK2 NHSL1 MACF1 CNOT1 DNAH11 | 1.99e-07 | 1431 | 238 | 29 | 37142655 | |
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 2.22e-07 | 38 | 238 | 6 | 12791264 | |
| Pubmed | SMG1 SP100 ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 FAM47B TOMM20 ERBIN TUFM AP2A2 AHNAK SCN4A DLG2 DLEC1 AP3D1 SFN PPP1R9A CAMSAP3 ACTR2 KIAA0825 CEP112 MACF1 POLQ CFAP46 UTP14C | 2.33e-07 | 1442 | 238 | 29 | 35575683 | |
| Pubmed | Perturbation of the mutated EGFR interactome identifies vulnerabilities and resistance mechanisms. | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 TUFM AP2A2 AHNAK SFN AAK1 | 2.34e-07 | 256 | 238 | 12 | 24189400 |
| Pubmed | 3.16e-07 | 3 | 238 | 3 | 35507432 | ||
| Pubmed | Actin and myosin genes are transcriptionally regulated during mouse skeletal muscle development. | 3.16e-07 | 3 | 238 | 3 | 1728592 | |
| Pubmed | Restricted morphological and behavioral abnormalities following ablation of β-actin in the brain. | 3.16e-07 | 3 | 238 | 3 | 22403730 | |
| Pubmed | Reexamination of chromosomal loci of human muscle actin genes by fluorescence in situ hybridization. | 3.16e-07 | 3 | 238 | 3 | 7780165 | |
| Pubmed | 3.16e-07 | 3 | 238 | 3 | 6865942 | ||
| Pubmed | POM121 inhibits the macrophage inflammatory response by impacting NF-κB P65 nuclear accumulation. | 3.16e-07 | 3 | 238 | 3 | 30802453 | |
| Pubmed | 3.16e-07 | 3 | 238 | 3 | 3842206 | ||
| Pubmed | 3.16e-07 | 3 | 238 | 3 | 6641707 | ||
| Pubmed | 3.16e-07 | 3 | 238 | 3 | 3084797 | ||
| Pubmed | 3.38e-07 | 96 | 238 | 8 | 23580065 | ||
| Pubmed | Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. | HIF1A ERV3-1 MAPT ATXN7L1 RABGAP1 ERBIN SH3BP4 SHKBP1 STK10 TOX3 AFF1 LUZP2 PMS2P2 CDC42BPG TUT4 PPP1R9A RALGAPB CAMSAP3 AAK1 RNF213 BTAF1 IQCN CDC42EP3 JMJD1C ZNF532 SETBP1 MACF1 CNOT1 PDZD2 | 4.49e-07 | 1489 | 238 | 29 | 28611215 |
| Pubmed | 4.76e-07 | 43 | 238 | 6 | 20876399 | ||
| Pubmed | SMG1 ZHX3 ERBIN AP2A2 DMXL2 RALGAPB MED13L TTC7A MYOF SETBP1 MACF1 | 4.95e-07 | 225 | 238 | 11 | 12168954 | |
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | ZHX3 ACTA1 NACA ERBIN EMSY TDRD3 AHNAK BUB1B CIZ1 FERMT2 AP3D1 NUP153 NUP107 AAK1 DNM1L TACC2 BTAF1 NUP214 RFC1 POM121C MACF1 SON | 5.70e-07 | 934 | 238 | 22 | 33916271 |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | CHAF1B ACTBL2 ACTA1 NACA ACTC1 ACTG1 RB1CC1 TUFM DHX8 CEP350 POM121 AHNAK CIZ1 AFDN NUP153 NUP107 PPP1R9A BTAF1 NUP214 ACTR2 MACF1 CNOT1 SON | 7.06e-07 | 1024 | 238 | 23 | 24711643 |
| Pubmed | A Degradation Motif in STAU1 Defines a Novel Family of Proteins Involved in Inflammation. | MAPT RC3H1 ACTA2 DHX8 CEP350 TDRD3 AHNAK ASCC2 SMG9 FERMT2 TUT4 ICE2 AAK1 ACTR2 MYOF GTF2H4 MACF1 CNOT1 SON | 7.14e-07 | 724 | 238 | 19 | 36232890 |
| Pubmed | The DNA sequence and biological annotation of human chromosome 1. | CDK18 PRAMEF25 PRAMEF9 RC3H1 GON4L TOMM20 PFKFB2 CEP350 TOMM40L EIF2B3 TDRD10 MTARC2 BCAR3 ALG6 PRAMEF11 SFN TUT4 PRAMEF4 RFX5 STRIP1 GPATCH3 MACF1 HSPB7 | 7.93e-07 | 1031 | 238 | 23 | 16710414 |
| Pubmed | Probing nuclear pore complex architecture with proximity-dependent biotinylation. | 1.03e-06 | 77 | 238 | 7 | 24927568 | |
| Pubmed | 1.26e-06 | 4 | 238 | 3 | 11812134 | ||
| Pubmed | The formin-homology-domain-containing protein FHOD1 enhances cell migration. | 1.26e-06 | 4 | 238 | 3 | 12665555 | |
| Pubmed | Two distinct human POM121 genes: requirement for the formation of nuclear pore complexes. | 1.26e-06 | 4 | 238 | 3 | 17900573 | |
| Pubmed | 1.26e-06 | 4 | 238 | 3 | 2201580 | ||
| Pubmed | SH3BP4 STK10 BRD8 AFDN BCAR3 ANKRD52 NUP153 SFN NUP107 CAMSAP3 AAK1 TACC2 RFC1 STRIP1 SON | 2.35e-06 | 503 | 238 | 15 | 16964243 | |
| Pubmed | 2.75e-06 | 15 | 238 | 4 | 24598388 | ||
| Pubmed | Identification of a novel actin isoform in hepatocellular carcinoma. | 2.75e-06 | 15 | 238 | 4 | 16824795 | |
| Pubmed | SMG1 NACA GON4L TUFM SH3BP4 WASHC5 BUB1B AFDN AP3D1 CDC42BPG DMXL2 RALGAPB CAMSAP3 BTAF1 JMJD1C POLR3A RHPN2 | 2.92e-06 | 650 | 238 | 17 | 38777146 | |
| Pubmed | Distinct domain utilization by Smad3 and Smad4 for nucleoporin interaction and nuclear import. | 3.13e-06 | 5 | 238 | 3 | 12917407 | |
| Pubmed | Microtubule associated protein MAP1A is an actin-binding and crosslinking protein. | 3.13e-06 | 5 | 238 | 3 | 7820861 | |
| Pubmed | D186/D190 is an allele-dependent determinant of HIV-1 Nef function. | 3.13e-06 | 5 | 238 | 3 | 27560372 | |
| Pubmed | SMG1 HIVEP1 ACTB ACTG1 ERBIN ACOX3 AP2A2 ASCC2 AFF1 PLAG1 AFDN ZNF106 UBXN11 MACF1 SMAD3 SON | 3.72e-06 | 591 | 238 | 16 | 15231748 | |
| Pubmed | ACTBL2 ACTA1 ACTB ACTG1 RB1CC1 ERBIN ASAP1 SHKBP1 CEP350 PTPN3 TDRD3 WASHC5 AHNAK ANKRD52 NUP153 NUP107 PPP1R9A RALGAPB CAMSAP3 RNF213 NHSL1 CNOT1 | 3.76e-06 | 1049 | 238 | 22 | 27880917 | |
| Pubmed | 6.23e-06 | 6 | 238 | 3 | 12679033 | ||
| Pubmed | 6.23e-06 | 6 | 238 | 3 | 16881058 | ||
| Pubmed | Comprehensive proteomic analysis of interphase and mitotic 14-3-3-binding proteins. | 7.10e-06 | 190 | 238 | 9 | 15161933 | |
| Pubmed | HIVEP1 RABGAP1 RB1CC1 AHNAK BUB1B ANKRD52 NUP107 CAMSAP3 MSANTD2 NUP214 JMJD1C ZNF532 CNOT1 | 7.16e-06 | 418 | 238 | 13 | 34709266 | |
| Pubmed | SMG1 CHAF1B HIP1 ACTBL2 NACA ACTA2 TSC2 ERBIN TUFM AP2A2 AHNAK EIF2B3 BUB1B ASCC2 AP3D1 RNF213 BTAF1 MRPL45 RFC1 ACTR2 POLR3A MYOF ASNS ZW10 CTSB CNOT1 | 7.17e-06 | 1440 | 238 | 26 | 30833792 | |
| Pubmed | NACA CEP350 TDRD3 WASHC5 AHNAK NUP214 MRPL45 VIRMA JMJD1C ZNF106 | 7.34e-06 | 242 | 238 | 10 | 34011540 | |
| Pubmed | 7.65e-06 | 19 | 238 | 4 | 30700554 | ||
| Pubmed | 7.79e-06 | 40 | 238 | 5 | 27197753 | ||
| Pubmed | Biological, clinical and population relevance of 95 loci for blood lipids. | 8.00e-06 | 146 | 238 | 8 | 20686565 | |
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | HIP1 THAP8 TSC2 ACOX3 SH3BP4 FOCAD STK10 TDRD3 AHNAK EIF2B3 SCN8A AP3D1 UNC13B BTAF1 NUP214 REV3L MED13L POM121C NHSL1 MYOF ADAMTS7 CD276 | 8.52e-06 | 1105 | 238 | 22 | 35748872 |
| Pubmed | GRIPAP1 RC3H1 CEP350 POM121 AP2A2 DMXL2 BAZ2B RNF213 POM121C JMJD1C MYOF MACF1 POM121B UTP14C | 8.92e-06 | 493 | 238 | 14 | 15368895 | |
| Pubmed | 9.51e-06 | 20 | 238 | 4 | 26694250 | ||
| Pubmed | 9.76e-06 | 250 | 238 | 10 | 33536335 | ||
| Pubmed | GRIPAP1 CEP350 TDRD3 WASHC5 LRCH2 NUP107 ICE2 CAMSAP3 POLR3A CNOT1 | 1.01e-05 | 251 | 238 | 10 | 29778605 | |
| Interaction | YWHAB interactions | CDK18 CHAF1B HIVEP1 MAPT RC3H1 ACTA2 ACTB ACTC1 ACTG1 DAPK1 TSC2 PFKFB2 RB1CC1 ERBIN SH3BP4 SHKBP1 CEP350 PTPN3 AFDN SFN STK25 NUP107 RALGAPB CAMSAP3 AAK1 DNM1L CHORDC1 ATF2 VIRMA ACTR2 NHSL1 ZNF106 CEP112 MACF1 SON | 6.62e-09 | 1014 | 233 | 35 | int:YWHAB |
| Interaction | ERRFI1 interactions | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 RB1CC1 BCAR3 SFN ARRDC5 | 4.56e-08 | 107 | 233 | 11 | int:ERRFI1 |
| Interaction | CAP2 interactions | 6.60e-08 | 66 | 233 | 9 | int:CAP2 | |
| Interaction | LIMA1 interactions | ARHGAP24 ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 DAPK1 TOMM20 SH3BP4 AP2A2 AHNAK AFDN SFN PPP1R9A VIRMA ACTR2 PLEKHG6 LSP1 | 1.45e-07 | 429 | 233 | 20 | int:LIMA1 |
| Interaction | SCIN interactions | 3.30e-07 | 58 | 233 | 8 | int:SCIN | |
| Interaction | VCL interactions | ARHGAP24 ACTA1 ACTB DAG1 ACTC1 ACTG1 ASAP1 FOCAD BUB1B ASCC2 FERMT2 SFN CCDC80 VIRMA ASNS MACF1 | 5.70e-07 | 305 | 233 | 16 | int:VCL |
| Interaction | DNASE1 interactions | 5.93e-07 | 7 | 233 | 4 | int:DNASE1 | |
| Interaction | APC interactions | TOMM20 RB1CC1 ERBIN ASAP1 POM121 BUB1B AFDN NUP153 SFN NUP107 NUP214 IQCN POM121C VIRMA ZNF106 CCDC71 MACF1 ZW10 | 6.94e-07 | 389 | 233 | 18 | int:APC |
| Interaction | PHACTR2 interactions | 8.52e-07 | 29 | 233 | 6 | int:PHACTR2 | |
| Interaction | NUP43 interactions | HIVEP1 ACTC1 GON4L EMSY DHX8 BRD8 POM121 TOX3 BUB1B CIZ1 NUP153 NUP107 BAZ2B NUP214 RFC1 POM121C VIRMA JMJD1C TAF3 ZNF532 CNOT1 SON PDZD2 | 1.08e-06 | 625 | 233 | 23 | int:NUP43 |
| Interaction | NEXN interactions | 1.09e-06 | 91 | 233 | 9 | int:NEXN | |
| Interaction | ACTG2 interactions | 1.43e-06 | 49 | 233 | 7 | int:ACTG2 | |
| Interaction | PFN1 interactions | ARHGAP24 ACTA1 ACTA2 ACTB ACTC1 ACTG1 RABGAP1 STING1 CEP350 TDRD3 AFDN RALGAPB AAK1 DNM1L ATF2 VIRMA ACTR2 NHSL1 MACF1 CNOT1 | 2.10e-06 | 509 | 233 | 20 | int:PFN1 |
| Interaction | POTEJ interactions | 2.17e-06 | 52 | 233 | 7 | int:POTEJ | |
| Interaction | NUP50 interactions | CHAF1B NACA ACTC1 STING1 DHX8 STK10 POM121 NUP153 NUP107 BTAF1 NUP214 RFC1 VIRMA TAF3 ASNS SON | 2.45e-06 | 341 | 233 | 16 | int:NUP50 |
| Interaction | PFN3 interactions | 3.46e-06 | 10 | 233 | 4 | int:PFN3 | |
| Interaction | WASH8P interactions | 5.39e-06 | 11 | 233 | 4 | int:WASH8P | |
| Interaction | LRRK2 interactions | TCP10L HIF1A MAPT ACTBL2 NACA ACTA2 ACTB ACTG1 ACTG2 DAPK1 FAM47B APEX2 AHNAK SFN STK25 DNM1L CDC42EP3 ACTR2 RASL11B | 5.50e-06 | 496 | 233 | 19 | int:LRRK2 |
| Interaction | CAP1 interactions | ARHGAP24 MAPT ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 STING1 TUFM ATF2 VIRMA | 5.53e-06 | 207 | 233 | 12 | int:CAP1 |
| Interaction | GSN interactions | ARHGAP24 ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 DAPK1 STING1 ACTR2 PLEKHG6 LSP1 | 7.05e-06 | 212 | 233 | 12 | int:GSN |
| Interaction | GC interactions | 7.23e-06 | 62 | 233 | 7 | int:GC | |
| Interaction | MAP1A interactions | 8.85e-06 | 117 | 233 | 9 | int:MAP1A | |
| Interaction | CFL1 interactions | ARHGAP24 MAPT ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 STING1 ARHGAP31 NUP214 ATF2 VIRMA ACTR2 CEP112 | 1.10e-05 | 384 | 233 | 16 | int:CFL1 |
| Interaction | PDCL3 interactions | 2.11e-05 | 100 | 233 | 8 | int:PDCL3 | |
| Interaction | FBXO40 interactions | 2.15e-05 | 15 | 233 | 4 | int:FBXO40 | |
| Interaction | NAA80 interactions | 2.15e-05 | 15 | 233 | 4 | int:NAA80 | |
| Interaction | YWHAZ interactions | CDK18 NRG1 CHAF1B HIVEP1 MAPT ACTA1 ACTC1 ACTG1 TSC2 PFKFB2 RB1CC1 ERBIN TUFM SH3BP4 PTPN3 AFDN FERMT2 SFN STK25 CDC42BPG DMXL2 NUP107 RALGAPB CAMSAP3 AAK1 DNM1L TACC2 VIRMA ACTR2 NUAK2 NHSL1 CEP112 MACF1 | 2.32e-05 | 1319 | 233 | 33 | int:YWHAZ |
| Interaction | POTEI interactions | 3.01e-05 | 105 | 233 | 8 | int:POTEI | |
| Interaction | YWHAH interactions | CDK18 HIVEP1 MAPT TSC2 PFKFB2 RB1CC1 ERBIN SH3BP4 SHKBP1 CEP350 PTPN3 AHNAK AFDN FERMT2 SFN CDC42BPG LRCH2 RALGAPB CAMSAP3 AAK1 DNM1L VIRMA ACTR2 NUAK2 NHSL1 ZNF106 RHPN2 CEP112 MACF1 | 3.08e-05 | 1102 | 233 | 29 | int:YWHAH |
| Interaction | COBL interactions | 3.32e-05 | 78 | 233 | 7 | int:COBL | |
| Interaction | REG3A interactions | 3.68e-05 | 17 | 233 | 4 | int:REG3A | |
| Interaction | TMSB4X interactions | 3.91e-05 | 80 | 233 | 7 | int:TMSB4X | |
| Interaction | MRGBP interactions | 3.94e-05 | 109 | 233 | 8 | int:MRGBP | |
| Interaction | VASP interactions | HIF1A ACTA1 ACTB ACTC1 ACTG1 STING1 CEP350 BUB1B FERMT2 ANKRD52 AAK1 VIRMA NHSL1 | 4.06e-05 | 294 | 233 | 13 | int:VASP |
| Interaction | CD2AP interactions | TCP10L MAPT ACTB ACTC1 STING1 ASAP1 WASHC5 SFN VIRMA DACH2 ASNS | 4.15e-05 | 214 | 233 | 11 | int:CD2AP |
| Interaction | ACTBL2 interactions | MAPT RC3H1 ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 ADA PXK NUP107 LSP1 | 4.35e-05 | 296 | 233 | 13 | int:ACTBL2 |
| Interaction | PLEC interactions | HIP1 ACTBL2 ACTA1 NACA ACTA2 ACTB ACTC1 ACTG1 ACTG2 STING1 AHNAK SFN MXRA5 AAK1 VIRMA MACF1 | 4.36e-05 | 430 | 233 | 16 | int:PLEC |
| Interaction | NUAK2 interactions | 4.49e-05 | 56 | 233 | 6 | int:NUAK2 | |
| Interaction | TMOD2 interactions | 4.59e-05 | 82 | 233 | 7 | int:TMOD2 | |
| Interaction | TRIM21 interactions | ZHX3 HIF1A MAPT RC3H1 ACTBL2 ACTA1 ACTA2 ACTB ACTG1 PFKFB2 RB1CC1 ADGRG4 TUFM AHNAK SCN8A SFN VIRMA IFNAR2 CD14 RHPN2 XAF1 | 5.41e-05 | 689 | 233 | 21 | int:TRIM21 |
| Interaction | YWHAE interactions | CDK18 CHAF1B HIVEP1 MAPT RC3H1 ACTA2 ACTB ACTC1 TSC2 STING1 PFKFB2 RB1CC1 ERBIN SH3BP4 PTPN3 AFDN FERMT2 SFN LRCH2 RALGAPB CAMSAP3 AAK1 DNM1L TACC2 VIRMA ACTR2 NUAK2 ZNF106 CEP112 ASNS MACF1 | 5.42e-05 | 1256 | 233 | 31 | int:YWHAE |
| Interaction | ABRA interactions | 5.57e-05 | 36 | 233 | 5 | int:ABRA | |
| Interaction | LRRC20 interactions | 5.89e-05 | 19 | 233 | 4 | int:LRRC20 | |
| Interaction | MYO6 interactions | MAPT ACTBL2 ACTA1 ACTC1 ACTG1 DAPK1 TUFM SH3BP4 AP2A2 AP3D1 LRCH2 PPP1R9A VIRMA ACTR2 CTSB | 6.56e-05 | 398 | 233 | 15 | int:MYO6 |
| Interaction | MRTFA interactions | 6.66e-05 | 60 | 233 | 6 | int:MRTFA | |
| Interaction | H2BC9 interactions | NRG1 HIF1A ARHGAP24 HIVEP1 ACTA2 DAPK1 FAM47B ADGRG4 CEP350 TDRD3 AHNAK LRCH2 BAZ2B TEX15 VIRMA SETBP1 | 6.72e-05 | 446 | 233 | 16 | int:H2BC9 |
| Interaction | CTTN interactions | ARHGAP24 MAPT ACTA1 ACTB ACTC1 ACTG1 DAPK1 RB1CC1 ASAP1 FOCAD AHNAK PPP1R9A ATF2 ACTR2 STRIP1 CNOT1 | 7.46e-05 | 450 | 233 | 16 | int:CTTN |
| Interaction | EZR interactions | ARHGAP24 MAPT ACTA2 ACTB ACTC1 STING1 ERBIN ASAP1 STK10 TDRD3 WASHC5 AHNAK FERMT2 NUP107 PPP1R9A DNM1L VIRMA MACF1 | 8.24e-05 | 553 | 233 | 18 | int:EZR |
| Interaction | SORBS1 interactions | 9.31e-05 | 123 | 233 | 8 | int:SORBS1 | |
| Interaction | NUP214 interactions | STING1 EMSY NUP153 NUP107 NUP214 CHORDC1 VIRMA STRIP1 PLEKHG6 SMAD3 | 9.46e-05 | 195 | 233 | 10 | int:NUP214 |
| Interaction | YWHAQ interactions | CDK18 MAPT RC3H1 ACTA2 ACTB ACTG1 DAPK1 TSC2 PFKFB2 ERBIN SH3BP4 CEP350 PTPN3 USP42 AFDN SFN NUP107 CAMSAP3 AAK1 DNM1L RFC1 VIRMA ACTR2 NHSL1 ZNF106 CEP112 IGHG2 MACF1 | 1.00e-04 | 1118 | 233 | 28 | int:YWHAQ |
| Interaction | PXK interactions | 1.06e-04 | 41 | 233 | 5 | int:PXK | |
| Interaction | DBN1 interactions | ARHGAP24 MAPT ACTBL2 ACTA2 ACTB ACTC1 ACTG1 DAPK1 RB1CC1 ERBIN AP2A2 AFDN PPP1R9A DNM1L ACTR2 | 1.10e-04 | 417 | 233 | 15 | int:DBN1 |
| Interaction | ACTA1 interactions | HIF1A MAPT RC3H1 ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 RABGAP1 SFN ACTR2 MACF1 | 1.13e-04 | 371 | 233 | 14 | int:ACTA1 |
| Interaction | JCAD interactions | 1.19e-04 | 42 | 233 | 5 | int:JCAD | |
| Interaction | EIF5A interactions | SP100 ACTC1 STING1 DHX8 PTPN3 NUP153 NUP107 DNM1L ATF2 VIRMA ZNF532 MACF1 | 1.19e-04 | 283 | 233 | 12 | int:EIF5A |
| Interaction | TASL interactions | 1.22e-04 | 9 | 233 | 3 | int:TASL | |
| Interaction | PPP1R9A interactions | 1.23e-04 | 128 | 233 | 8 | int:PPP1R9A | |
| Interaction | ZYX interactions | ACTA2 ACTB ACTC1 STING1 ERBIN CEP350 ARHGAP31 BUB1B FERMT2 AAK1 FSD2 MACF1 CNOT1 | 1.26e-04 | 329 | 233 | 13 | int:ZYX |
| Interaction | ARHGAP12 interactions | 1.35e-04 | 68 | 233 | 6 | int:ARHGAP12 | |
| Interaction | TRIM37 interactions | HIF1A ACTBL2 ACTA1 NACA ACTB ACTC1 STING1 TUFM CEP350 APEX2 ARHGAP31 AHNAK BUB1B RFX5 VIRMA JMJD1C ACTR2 MYOF FAM124B | 1.42e-04 | 630 | 233 | 19 | int:TRIM37 |
| Interaction | CAPZA2 interactions | MAPT ACTA1 ACTB ACTC1 ACTG1 DAPK1 WASHC5 AHNAK AFDN PPP1R9A VIRMA ACTR2 ZNF106 MACF1 CNOT1 | 1.54e-04 | 430 | 233 | 15 | int:CAPZA2 |
| Interaction | TTC23 interactions | 1.61e-04 | 208 | 233 | 10 | int:TTC23 | |
| Interaction | TWF2 interactions | 1.62e-04 | 100 | 233 | 7 | int:TWF2 | |
| Interaction | PLEKHG3 interactions | 1.62e-04 | 100 | 233 | 7 | int:PLEKHG3 | |
| Interaction | SFN interactions | HIF1A MAPT ACTA1 ACTA2 ACTG1 TSC2 ERBIN SH3BP4 CEP350 PTPN3 SFN CAMSAP3 AAK1 DNM1L ATF2 VIRMA NUAK2 RHPN2 CEP112 MACF1 | 1.67e-04 | 692 | 233 | 20 | int:SFN |
| Interaction | POTEE interactions | 1.69e-04 | 134 | 233 | 8 | int:POTEE | |
| Interaction | ANGPTL8 interactions | 1.72e-04 | 10 | 233 | 3 | int:ANGPTL8 | |
| Interaction | PPP1CA interactions | SP100 MAPT ACTA1 NACA ACTB ACTG1 TSC2 RABGAP1 RB1CC1 ERBIN SHKBP1 NUP153 SFN PPP1R9A CAMSAP3 AAK1 VIRMA POLR3A ASNS SON | 1.80e-04 | 696 | 233 | 20 | int:PPP1CA |
| Interaction | MCC interactions | BRPF3 ERBIN CEP350 PTPN3 ZNF438 VIRMA POLR3A STRIP1 GTF2H4 UTP14C | 2.10e-04 | 215 | 233 | 10 | int:MCC |
| Interaction | SIK2 interactions | 2.33e-04 | 106 | 233 | 7 | int:SIK2 | |
| Interaction | SPIRE1 interactions | 2.48e-04 | 27 | 233 | 4 | int:SPIRE1 | |
| Interaction | YWHAG interactions | CDK18 HIVEP1 MAPT RC3H1 ACTC1 TSC2 STING1 PFKFB2 RB1CC1 ERBIN SH3BP4 SHKBP1 CEP350 PTPN3 AFDN SFN RALGAPB CAMSAP3 AAK1 DNM1L ATF2 VIRMA ACTR2 NHSL1 ZNF106 RHPN2 CEP112 MACF1 SON | 2.68e-04 | 1248 | 233 | 29 | int:YWHAG |
| Interaction | MEX3B interactions | SMG1 RC3H1 SHKBP1 TDRD3 SMG9 TUT4 CAMSAP3 VIRMA STRIP1 CNOT1 | 2.72e-04 | 222 | 233 | 10 | int:MEX3B |
| Interaction | FBXO38 interactions | 2.90e-04 | 145 | 233 | 8 | int:FBXO38 | |
| Interaction | ACTR10 interactions | 2.93e-04 | 110 | 233 | 7 | int:ACTR10 | |
| Interaction | MIEF1 interactions | 3.01e-04 | 51 | 233 | 5 | int:MIEF1 | |
| Interaction | MAPK9 interactions | 3.25e-04 | 186 | 233 | 9 | int:MAPK9 | |
| Interaction | THRB interactions | 3.25e-04 | 186 | 233 | 9 | int:THRB | |
| Interaction | GREB1 interactions | 3.30e-04 | 29 | 233 | 4 | int:GREB1 | |
| Interaction | POTEF interactions | 3.36e-04 | 228 | 233 | 10 | int:POTEF | |
| Interaction | DSTN interactions | 3.38e-04 | 187 | 233 | 9 | int:DSTN | |
| Interaction | SIGLECL1 interactions | 3.45e-04 | 113 | 233 | 7 | int:SIGLECL1 | |
| Interaction | ARL15 interactions | 3.45e-04 | 113 | 233 | 7 | int:ARL15 | |
| Interaction | SLX4 interactions | ATXN7L1 NACA ACTB ACTC1 ACTG1 EMSY TUFM CEP350 AP2A2 SPTY2D1 NUP153 BAZ2B NUP214 REV3L VIRMA ZNF106 POLQ | 3.76e-04 | 572 | 233 | 17 | int:SLX4 |
| Interaction | PGAP1 interactions | 3.77e-04 | 30 | 233 | 4 | int:PGAP1 | |
| Interaction | C6orf47 interactions | 3.77e-04 | 30 | 233 | 4 | int:C6orf47 | |
| Interaction | ACTG1 interactions | ARHGAP24 MAPT RC3H1 ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 RABGAP1 PXK SFN PPP1R9A ACTR2 LSP1 | 3.83e-04 | 520 | 233 | 16 | int:ACTG1 |
| Interaction | PRAMEF4 interactions | 3.96e-04 | 3 | 233 | 2 | int:PRAMEF4 | |
| Interaction | KIAA0513 interactions | 4.01e-04 | 13 | 233 | 3 | int:KIAA0513 | |
| Interaction | PCYT1B interactions | 4.01e-04 | 13 | 233 | 3 | int:PCYT1B | |
| Interaction | NPTN interactions | SMG1 ACTBL2 ACTA2 TSC2 STING1 FOCAD DMXL2 MMS22L RNF213 BTAF1 ZW10 | 4.12e-04 | 278 | 233 | 11 | int:NPTN |
| Interaction | CCT5 interactions | CDK18 ARHGAP24 MAPT ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 STING1 ACOX3 BMX AHNAK ATF2 VIRMA ACTR2 | 4.25e-04 | 525 | 233 | 16 | int:CCT5 |
| Interaction | WASL interactions | 4.26e-04 | 117 | 233 | 7 | int:WASL | |
| Interaction | AP2B1 interactions | HIP1 ARHGAP24 MAPT RC3H1 CEP350 POM121 AP2A2 RAPGEF3 BUB1B ICE2 RALGAPB AAK1 VIRMA | 4.26e-04 | 373 | 233 | 13 | int:AP2B1 |
| Interaction | NEK4 interactions | NRG1 PSG6 ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 PFKFB2 EMSY TUFM SFN DOK1 CAMSAP3 VIRMA SETBP1 | 4.58e-04 | 582 | 233 | 17 | int:NEK4 |
| Interaction | FBXO30 interactions | 4.68e-04 | 56 | 233 | 5 | int:FBXO30 | |
| Interaction | TMSB10 interactions | 4.68e-04 | 56 | 233 | 5 | int:TMSB10 | |
| Interaction | PPP1R2B interactions | 5.05e-04 | 14 | 233 | 3 | int:PPP1R2B | |
| Interaction | RNASE3 interactions | 5.05e-04 | 14 | 233 | 3 | int:RNASE3 | |
| Cytoband | 1p36.21 | 1.97e-05 | 63 | 238 | 5 | 1p36.21 | |
| Cytoband | 7q11.23 | 1.57e-04 | 97 | 238 | 5 | 7q11.23 | |
| Cytoband | 10q22-q23 | 2.65e-04 | 5 | 238 | 2 | 10q22-q23 | |
| GeneFamily | Actins | 2.95e-13 | 6 | 150 | 6 | 929 | |
| GeneFamily | PRAME family | 3.51e-08 | 24 | 150 | 6 | 686 | |
| GeneFamily | PDZ domain containing | 3.98e-05 | 152 | 150 | 8 | 1220 | |
| GeneFamily | Nucleoporins | 1.37e-04 | 32 | 150 | 4 | 1051 | |
| GeneFamily | Pleckstrin homology domain containing|Rho guanine nucleotide exchange factors|C2 domain containing | 3.27e-04 | 206 | 150 | 8 | 682 | |
| GeneFamily | Ankyrin repeat domain containing|Death associated protein kinases | 6.73e-04 | 5 | 150 | 2 | 1021 | |
| GeneFamily | PHD finger proteins | 9.17e-04 | 90 | 150 | 5 | 88 | |
| GeneFamily | Adhesion G protein-coupled receptors, subfamily G | 1.40e-03 | 7 | 150 | 2 | 917 | |
| GeneFamily | Sodium voltage-gated channel alpha subunits | 2.37e-03 | 9 | 150 | 2 | 1203 | |
| GeneFamily | Armadillo repeat containing|Protein phosphatase 1 regulatory subunits | 4.04e-03 | 181 | 150 | 6 | 694 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_DN | ZHX3 NRG1 SP100 HIF1A HIVEP1 DAPK1 RABGAP1 RB1CC1 CEP350 STK10 TDRD3 BUB1B AFF1 BCAR3 FERMT2 NUP153 DMXL2 TUT4 BAZ2B BTAF1 REV3L MED13L ATF2 MYOF MACF1 SMAD3 SON | 1.96e-08 | 856 | 237 | 27 | M4500 |
| Coexpression | DAZARD_RESPONSE_TO_UV_NHEK_DN | CEP350 PTPN3 BRD8 BUB1B AFF1 BCAR3 FERMT2 NUP153 TUT4 BAZ2B REV3L MED13L ATF2 SMAD3 | 6.83e-07 | 300 | 237 | 14 | M8702 |
| Coexpression | SASSON_RESPONSE_TO_FORSKOLIN_DN | 1.05e-06 | 85 | 237 | 8 | M12924 | |
| Coexpression | DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN | ZHX3 NRG1 HIVEP1 DAPK1 RABGAP1 CEP350 BUB1B AFF1 BCAR3 FERMT2 NUP153 TUT4 BAZ2B REV3L MED13L ATF2 SMAD3 | 1.35e-06 | 466 | 237 | 17 | M13522 |
| Coexpression | GSE19888_ADENOSINE_A3R_INH_PRETREAT_AND_ACT_BY_A3R_VS_A3R_INH_AND_TCELL_MEMBRANES_ACT_MAST_CELL_UP | ATXN7L1 BBS1 RABGAP1 RB1CC1 ERBIN ASAP1 AMN1 BAZ2B MED13L ZNF106 KDM7A | 1.69e-06 | 194 | 237 | 11 | M7313 |
| Coexpression | GSE360_L_DONOVANI_VS_B_MALAYI_HIGH_DOSE_DC_DN | 1.45e-05 | 199 | 237 | 10 | M5201 | |
| Coexpression | GSE21063_3H_VS_16H_ANTI_IGM_STIM_BCELL_UP | 1.52e-05 | 200 | 237 | 10 | M8264 | |
| Coexpression | GSE41176_UNSTIM_VS_ANTI_IGM_STIM_BCELL_6H_DN | GRIPAP1 RABGAP1 RB1CC1 ADA PTPN3 AP2A2 INTS6L TEF IKZF5 DGKI | 1.52e-05 | 200 | 237 | 10 | M9923 |
| Coexpression | IVANOVA_HEMATOPOIESIS_MATURE_CELL | TCP10L GRIPAP1 ACTA2 AP2A2 INTS6L AAK1 CDC42EP3 CD14 ASNS GPCPD1 KDM7A CTSB | 1.91e-05 | 298 | 237 | 12 | M11205 |
| Coexpression | GAO_ESOPHAGUS_25W_C1_CILIATED_EPITHELIAL_CELLS | ODAD1 RGS22 BBS1 C8orf34 PLCB2 DLEC1 CFAP47 C16orf46 UBXN11 ATP6V0A4 MACF1 AGBL2 POLQ CFAP46 DNAH11 | 2.10e-05 | 459 | 237 | 15 | M39136 |
| Coexpression | IVANOVA_HEMATOPOIESIS_MATURE_CELL | TCP10L GRIPAP1 ACTA2 AP2A2 INTS6L AAK1 CDC42EP3 CD14 ASNS GPCPD1 KDM7A CTSB | 3.49e-05 | 317 | 237 | 12 | MM1163 |
| Coexpression | BUSSLINGER_GASTRIC_IMMUNE_CELLS | SMG1 ACTB STING1 RB1CC1 ERBIN ASAP1 CEP350 STK10 USP42 AHNAK PLCB2 NUP153 INTS6L TUT4 RALGAPB AAK1 RNF213 BTAF1 REV3L RFX5 ATF2 CDC42EP3 JMJD1C ACTR2 IFNAR2 GPCPD1 MACF1 LSP1 CNOT1 SON | 3.57e-05 | 1492 | 237 | 30 | M40023 |
| Coexpression | NAKAYA_PBMC_FLUMIST_AGE_18_50YO_3DY_DN | TTC39B BRPF3 HIVEP1 RC3H1 RB1CC1 EMSY DHX8 POM121 USP42 NUP153 SFN RFC1 CHORDC1 POM121C VIRMA JMJD1C GPCPD1 SON | 5.18e-05 | 680 | 237 | 18 | M41089 |
| Coexpression | WANG_TARGETS_OF_MLL_CBP_FUSION_UP | 5.27e-05 | 45 | 237 | 5 | M1440 | |
| Coexpression | TRAVAGLINI_LUNG_ALVEOLAR_EPITHELIAL_TYPE_1_CELL | HIP1 CYP4B1 DAPK2 ACTB ACTG1 RTKN2 AHNAK FERMT2 SFN RNF213 TTC7A NHSL1 PDZD2 | 6.28e-05 | 391 | 237 | 13 | M41659 |
| Coexpression | GSE19888_CTRL_VS_A3R_INHIBITOR_TREATED_MAST_CELL_DN | 7.54e-05 | 195 | 237 | 9 | M7310 | |
| Coexpression | GSE17974_0.5H_VS_72H_IL4_AND_ANTI_IL12_ACT_CD4_TCELL_UP | 7.84e-05 | 196 | 237 | 9 | M4244 | |
| Coexpression | GSE19198_6H_VS_24H_IL21_TREATED_TCELL_DN | 8.48e-05 | 198 | 237 | 9 | M7228 | |
| Coexpression | GSE2405_HEAT_KILLED_VS_LIVE_A_PHAGOCYTOPHILUM_STIM_NEUTROPHIL_24H_UP | 8.81e-05 | 199 | 237 | 9 | M6218 | |
| Coexpression | GSE2770_IL12_VS_IL4_TREATED_ACT_CD4_TCELL_48H_DN | 8.81e-05 | 199 | 237 | 9 | M6030 | |
| Coexpression | GSE16450_IMMATURE_VS_MATURE_NEURON_CELL_LINE_12H_IFNA_STIM_UP | 9.15e-05 | 200 | 237 | 9 | M7430 | |
| Coexpression | GSE23695_CD57_POS_VS_NEG_NK_CELL_DN | 9.15e-05 | 200 | 237 | 9 | M7786 | |
| Coexpression | GSE24210_CTRL_VS_IL35_TREATED_TCONV_CD4_TCELL_UP | 9.15e-05 | 200 | 237 | 9 | M7841 | |
| Coexpression | WANG_TARGETS_OF_MLL_CBP_FUSION_UP | 1.06e-04 | 52 | 237 | 5 | MM628 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | HIP1 ARHGAP24 HIVEP1 MAPT CYP4B1 ATXN7L1 USP42 ARHGAP31 RAPGEF3 AHNAK FERMT2 CDC42BPG BTAF1 CDC42EP3 IKZF5 MYOF MACF1 KDM7A EML1 SON | 1.07e-04 | 854 | 237 | 20 | M1533 |
| Coexpression | LAKE_ADULT_KIDNEY_C5_PROXIMAL_TUBULE_EPITHELIAL_CELLS_STRESS_INFLAM | ZHX3 NRG1 HIP1 MAPT ATXN7L1 GON4L RAPGEF3 DLG2 AP3D1 UNC13B RNF152 CFAP46 PDZD2 | 1.20e-04 | 417 | 237 | 13 | M39224 |
| Coexpression | LIAO_METASTASIS | NACA WDFY2 ASAP1 SHKBP1 USP42 TOX3 BUB1B SCN8A PLAG1 ANKRD52 PPP1R9A DNM1L TAF3 ZNF532 ASNS | 1.30e-04 | 540 | 237 | 15 | M13809 |
| Coexpression | DESCARTES_FETAL_STOMACH_CILIATED_EPITHELIAL_CELLS | CYP4B1 ODAD1 RGS22 C8orf34 DLEC1 CFAP47 KIAA0825 TTC29 AGBL2 CFAP46 DNAH11 | 1.59e-04 | 317 | 237 | 11 | M40298 |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_DN | 1.61e-04 | 265 | 237 | 10 | M1684 | |
| Coexpression | CUI_TCF21_TARGETS_2_DN | HIP1 ARHGAP24 HIVEP1 MAPT CYP4B1 ATXN7L1 USP42 ARHGAP31 RAPGEF3 AHNAK FERMT2 CDC42BPG BTAF1 CDC42EP3 IKZF5 MYOF MACF1 KDM7A EML1 SON | 1.80e-04 | 888 | 237 | 20 | MM1018 |
| Coexpression | DURCHDEWALD_SKIN_CARCINOGENESIS_DN | 1.99e-04 | 272 | 237 | 10 | MM1027 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#4_top-relative-expression-ranked_1000 | SMG1 ZHX3 ACTB RABGAP1 PFKFB2 CEP350 PLAG1 SPTY2D1 TUT4 PPP1R9A RALGAPB NUP214 REV3L RFX5 GPCPD1 | 1.15e-05 | 375 | 224 | 15 | gudmap_developingKidney_e15.5_cortic collect duct_1000_k4 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Medullary collecting duct_emap-28063_k-means-cluster#4_top-relative-expression-ranked_1000 | SMG1 GON4L RABGAP1 CEP350 AP2A2 PLAG1 SPTY2D1 TUT4 PPP1R9A NUP214 REV3L GPCPD1 | 2.28e-05 | 261 | 224 | 12 | gudmap_developingKidney_e15.5_Medullary collecting duct_1000_k4 |
| CoexpressionAtlas | dev gonad_e12.5_F_SupCellPrec_Sry_top-relative-expression-ranked_1000 | HIF1A RGS22 DAPK1 PTPN3 TDRD3 AHNAK AFF1 PLAG1 INTS6L RNF152 ICE2 CAMSAP3 RNF213 CCDC80 TEX15 REV3L MED13L IFNAR2 CEP112 ASNS GPCPD1 CNOT1 | 4.44e-05 | 803 | 224 | 22 | gudmap_dev gonad_e12.5_F_SupCellPrec_Sry_1000 |
| CoexpressionAtlas | kidney_adult_Mesangium_Meis_top-relative-expression-ranked_1000 | TTC39B SP100 HIP1 MAPT ATXN7L1 DAPK2 ACTA2 BMX ARHGAP31 RAPGEF3 AHNAK BCAR3 FERMT2 CCDC80 CDC42EP3 IFNAR2 CD14 HECTD2 CEP112 SETBP1 XAF1 MAML2 EML1 | 5.30e-05 | 872 | 224 | 23 | gudmap_kidney_adult_Mesangium_Meis_1000 |
| CoexpressionAtlas | kidney_adult_Podocyte_MafB_top-relative-expression-ranked_1000 | SP100 ARHGAP24 HIVEP1 MAPT RC3H1 DAG1 RB1CC1 PTPN3 RAPGEF3 AHNAK AFF1 BCAR3 FERMT2 AMN1 BTAF1 NUAK2 MYOF GPCPD1 MACF1 KDM7A EML1 CTSB | 8.30e-05 | 838 | 224 | 22 | gudmap_kidney_adult_Podocyte_MafB_1000 |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | CDK18 DAPK1 TOX3 ZNF483 AFF1 AFDN MXRA5 PPP1R9A VEPH1 TACC2 ATP6V0A4 KDM7A | 6.22e-10 | 194 | 237 | 12 | 04bfc555743f7d8821439d05ae442d15e9886c59 |
| ToppCell | COVID-19_Mild|World / Disease condition and Cell class | SMG1 SP100 HIF1A AHNAK DMXL2 RNF213 MED13L CD14 GPCPD1 XAF1 CTSB SMAD3 | 7.86e-10 | 198 | 237 | 12 | 61ceb2245b6cb58e308b999a61d218c89dbc615e |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | SMG1 HIF1A HIVEP1 ACTG1 ERBIN AFF1 SPTY2D1 SFN JMJD1C ITPKC KDM7A | 4.94e-09 | 185 | 237 | 11 | eb7d3c1363d5fedc611f9c1a91ea823de251355e |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Inner_Medullary_Collecting_Duct_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | CDK18 DAPK1 TOX3 ZNF483 AFF1 AFDN PPP1R9A VEPH1 TACC2 ATP6V0A4 KDM7A | 6.89e-09 | 191 | 237 | 11 | 3e828cffa24ded19f591a7ed6c1fe88ad57fdcac |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | CDK18 DAPK1 TOX3 AFF1 AFDN MXRA5 PPP1R9A VEPH1 TACC2 ATP6V0A4 KDM7A | 8.11e-09 | 194 | 237 | 11 | 69bff17df4a760ccf081cf52ff04af02c14f448d |
| ToppCell | nucseq-Epithelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | CYP4B1 DAPK2 C8orf34 RTKN2 DLG2 AFDN UNC13B PPP1R9A VEPH1 TACC2 PDZD2 | 8.55e-09 | 195 | 237 | 11 | 9406866f99555198a9be311fbd65751b70f35446 |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | SMG1 SP100 CEP350 AHNAK RNF213 BTAF1 MED13L JMJD1C MACF1 XAF1 SON | 1.11e-08 | 200 | 237 | 11 | 12f1685ce8f218433068e090c9d839cd5a1910bf |
| ToppCell | COVID-19-Epithelial_cells|COVID-19 / group, cell type (main and fine annotations) | CYP4B1 DAPK2 C8orf34 PTPN3 UNC13B PPP1R9A VEPH1 TACC2 PDZD2 DNAH11 | 7.15e-08 | 188 | 237 | 10 | c9cdee6f8d42ee69f5fb335f25084603c511bd29 |
| ToppCell | 10x5'-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8|lymph-node_spleen / Manually curated celltypes from each tissue | SMG1 AHNAK AAK1 RNF213 BTAF1 CHORDC1 JMJD1C GPCPD1 MACF1 MAML2 | 8.71e-08 | 192 | 237 | 10 | 47646d7e4990be85072987f92bf18d52f8da752e |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | CYP4B1 DAPK2 DAPK1 PFKFB2 C8orf34 UNC13B PPP1R9A VEPH1 TACC2 PDZD2 | 8.71e-08 | 192 | 237 | 10 | 29f49f00770c991b5f27e4cb701dd2d2d6cb7178 |
| ToppCell | COVID-19_Mild-Classical_Monocyte-cMono_4|COVID-19_Mild / Disease condition and Cell class | 1.06e-07 | 196 | 237 | 10 | 3729d1444c65cad640377894decc64129bc3fd5b | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_myocytic|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.11e-07 | 197 | 237 | 10 | e132f4b9deef6a565262c0aa0863cafe28f248e6 | |
| ToppCell | Bronchial-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | DAPK2 DAPK1 C8orf34 PTPN3 UNC13B PPP1R9A VEPH1 TACC2 NHSL1 PDZD2 | 1.22e-07 | 199 | 237 | 10 | 5f7da3eab58ace6cddb3179a415cd839d5767958 |
| ToppCell | 10x5'v1-week_14-16-Myeloid_monocytic|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | ACTB ACTG1 STING1 AHNAK DMXL2 NUP214 CDC42EP3 UBXN11 CD14 LSP1 | 1.22e-07 | 199 | 237 | 10 | 5caaf66b6cddcc8f0d0aee3c9ba80d02075e87e5 |
| ToppCell | 10x5'v1-week_14-16-Myeloid_monocytic-monocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | ACTB ACTG1 STING1 AHNAK DMXL2 NUP214 CDC42EP3 UBXN11 CD14 LSP1 | 1.22e-07 | 199 | 237 | 10 | 7f5d47e49776114d9f4a42017fead9eeb415a94c |
| ToppCell | 10x5'-bone_marrow-Lymphocytic_T_CD4-T_CD4/CD8|bone_marrow / Manually curated celltypes from each tissue | 1.63e-07 | 156 | 237 | 9 | 1545169694f686d28648a68b552c2ae606599d66 | |
| ToppCell | Control|World / group, cell type (main and fine annotations) | 3.07e-07 | 168 | 237 | 9 | a3511faf2cd2c2b9c8363c8b99da3f3609c43ed6 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | NRG1 ODAD1 C3orf20 PGAP1 CFAP47 KIAA0825 TTC29 CFAP46 DNAH11 | 3.22e-07 | 169 | 237 | 9 | fba841664939c771881ba97f14ef1df6635c04ff |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.54e-07 | 176 | 237 | 9 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 4.99e-07 | 178 | 237 | 9 | 0fb36679cddc9ed8f4b5b34e174d5133c2ea1c76 | |
| ToppCell | Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_2|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type. | 5.23e-07 | 179 | 237 | 9 | d95367d689732ab2653e8d70d8d8e5eb15ae6eef | |
| ToppCell | COVID-19-Epithelial_cells-AT1|COVID-19 / group, cell type (main and fine annotations) | 5.23e-07 | 179 | 237 | 9 | a0b33bd69ffdfd5d38d80207fb40058a490aa19e | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid-nan|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.01e-07 | 182 | 237 | 9 | f8c73baaaca145e2efc48f10f636feb79c8fc779 | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM2_(12)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 6.30e-07 | 183 | 237 | 9 | e84539978ab4de42e19186aed00f24bb50cbc21f | |
| ToppCell | Control-Neu_4|World / 5 Neutrophil clusters in COVID-19 patients | 6.59e-07 | 184 | 237 | 9 | ce7f044956613118ee2e9fb6af2455c3166cb414 | |
| ToppCell | COVID-19-Epithelial_cells-Airway_ciliated|COVID-19 / group, cell type (main and fine annotations) | 6.89e-07 | 185 | 237 | 9 | 18a40f0a338aa398d81384b5159fb80ce8a2020c | |
| ToppCell | droplet-Marrow-nan-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.89e-07 | 185 | 237 | 9 | 7adfa929930cfa795cbfbd9f1a0b439e08aa765d | |
| ToppCell | LPS_only|World / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 6.89e-07 | 185 | 237 | 9 | a72ccb147ca505880e2da8f6a70b9d570464a691 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.54e-07 | 187 | 237 | 9 | 5df9e1f5ca32217af255e76e6fb5afa346337811 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 7.89e-07 | 188 | 237 | 9 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.00e-07 | 191 | 237 | 9 | de2cd94ee88a7754f86d39469e38374d668210c7 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 9.00e-07 | 191 | 237 | 9 | ca5669bd6f4a17471acae3eb229f845cc2e08efa | |
| ToppCell | human_hepatoblastoma|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.81e-07 | 193 | 237 | 9 | e6a688bc834f845ff64dae1be64f073eec5091a1 | |
| ToppCell | severe-low-quality_cells|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 9.81e-07 | 193 | 237 | 9 | 9337bc93e3904c7fc7c93c328518bcd6453b1e8c | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 1.02e-06 | 194 | 237 | 9 | 53f3e49e91b1096f3226010e2de767efb490dfe4 | |
| ToppCell | NS-critical-d_07-13-Epithelial-Ciliated|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.02e-06 | 194 | 237 | 9 | 1ae8a10e508e672e6677f0e3c986ac30d05adeb3 | |
| ToppCell | LPS-IL1RA-Endothelial-Endothelial-Gen_Cap|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | ARHGAP31 TOX3 AFDN BAZ2B PPP1R9A DACH2 KIAA0825 MACF1 FAM124B | 1.02e-06 | 194 | 237 | 9 | 0b9cd96fa0b616da7cc90e92ff71157e9bba518f |
| ToppCell | 3'-GW_trimst-1-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.07e-06 | 195 | 237 | 9 | bd7526dd80a60ff7bc866e4f5a0e8acdbc10d191 | |
| ToppCell | Control-Classical_Monocyte-cMono_2|Control / Disease condition and Cell class | 1.07e-06 | 195 | 237 | 9 | 0fea64ee3eedf3929abb0dd9c5f5fc72f181eed9 | |
| ToppCell | COPD-Multiplet|COPD / Disease state, Lineage and Cell class | CYP4B1 C8orf34 CFAP47 CCDC80 TACC2 TTC29 MACF1 CFAP46 DNAH11 | 1.12e-06 | 196 | 237 | 9 | 6d02d494196e3f857d53eea46d9419690d43beca |
| ToppCell | COPD-Multiplet-Multiplet|COPD / Disease state, Lineage and Cell class | CYP4B1 C8orf34 CFAP47 CCDC80 TACC2 TTC29 MACF1 CFAP46 DNAH11 | 1.12e-06 | 196 | 237 | 9 | af4cdc61830685a888a1209826c23bcf54a43084 |
| ToppCell | severe-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.16e-06 | 197 | 237 | 9 | 57ebd552f10d6278623b52a3d484d4b91ae1d028 | |
| ToppCell | facs-Tongue-nan-3m-Epithelial|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-06 | 198 | 237 | 9 | 2f03f8897dd7cce6d8296638e14e11ec16bcf624 | |
| ToppCell | facs-Tongue-nan-3m|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-06 | 198 | 237 | 9 | f2a4057f038ef7225a5b98a7ab068c30dff4eadd | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-06 | 199 | 237 | 9 | 725610310e5c5fd7120c0be9acb55bf152026ddd | |
| ToppCell | Parenchymal-NucSeq-Epithelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-06 | 199 | 237 | 9 | 5cea0d9e261903e0eaad60c28a07dff72ce65027 | |
| ToppCell | (03)_KRT6B+-(2)_GFP_FOXI1|(03)_KRT6B+ / shred by cell type by condition | 1.27e-06 | 199 | 237 | 9 | c425e7975f492ed5cfcca022248adb627e1d27d4 | |
| ToppCell | mild-low-quality_cells|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 1.27e-06 | 199 | 237 | 9 | f0b0097df0026496470a80d8cc9375ffd8389b00 | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.27e-06 | 199 | 237 | 9 | 8587bd98de7767a575088afbea07a1feb4516b9b | |
| ToppCell | Control_saline-Endothelial-Endothelial-Gen_Cap|Control_saline / Treatment groups by lineage, cell group, cell type | 1.32e-06 | 200 | 237 | 9 | 3b97920e1e6e2f09ddba2a861baa9c00c2970f4c | |
| ToppCell | LPS_IL1RA-Endothelial-Endothelial-Gen_Cap|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 1.32e-06 | 200 | 237 | 9 | dccec522ab0d7fff62ad6273b02aa9022dbbb8eb | |
| ToppCell | COVID-19|World / Disease, condition lineage and cell class | 1.32e-06 | 200 | 237 | 9 | 7dec470c379cd89f05a0f37c8628b21f136e52f0 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-FOXN4+|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 2.05e-06 | 157 | 237 | 8 | 410c9d74a2085179cfb39853cb6d330fa98c9c1b | |
| ToppCell | E16.5-Mesenchymal-Mesenchymal_structural-Fibroblastic-AF1-AF1_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.20e-06 | 178 | 237 | 8 | c87945146b2734141f07b39d268e0d8086ee0364 | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 5.88e-06 | 181 | 237 | 8 | beb2771820956be8b190c0088ae3c4efdb53c897 | |
| ToppCell | 10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8|Liver / Manually curated celltypes from each tissue | 5.88e-06 | 181 | 237 | 8 | f2315414e714ac86211546a935660c4be6e85f1b | |
| ToppCell | Control-Epithelial_cells-Airway_ciliated|Control / group, cell type (main and fine annotations) | 6.13e-06 | 182 | 237 | 8 | fb725d10d9ed25dfc6d5bb69cfef78513f7d3e8f | |
| ToppCell | Adult-Epithelial-ciliated_cell-D122|Adult / Lineage, Cell type, age group and donor | 6.13e-06 | 182 | 237 | 8 | 7ded554a4b441e6496db673ba206c0d76ccad7d9 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.64e-06 | 184 | 237 | 8 | 57c792e6e2fedba25d3350ffe649fd74750b579d | |
| ToppCell | droplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.64e-06 | 184 | 237 | 8 | 1154a5ad7b8512272b7476f949ddac350910bfb7 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 6.64e-06 | 184 | 237 | 8 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D122|Adult / Lineage, Cell type, age group and donor | 6.64e-06 | 184 | 237 | 8 | 561592edc3083fad41b91811151b442207c65dd9 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 6.64e-06 | 184 | 237 | 8 | d7bd0f0c607bade67c99e9fb3578a570298bf926 | |
| ToppCell | droplet-Lung-LUNG-1m-Myeloid|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.91e-06 | 185 | 237 | 8 | 53a5218c1e6eb12daccde3d6e02f337e2586d74c | |
| ToppCell | NS-moderate-d_16-33-Epithelial-Ciliated|d_16-33 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.91e-06 | 185 | 237 | 8 | 5e689c2fb36ce3ac2adc8d15f67107f21cf68868 | |
| ToppCell | Adult-Epithelial-ciliated_cell-D175|Adult / Lineage, Cell type, age group and donor | 6.91e-06 | 185 | 237 | 8 | 30f4980dee6cd5959655f8d74049f3bfb5312611 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 6.91e-06 | 185 | 237 | 8 | e58a009aaf342be019a909747b1895d5987d4daf | |
| ToppCell | droplet-Spleen-nan-3m|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.18e-06 | 186 | 237 | 8 | 26f1e9930adf2fe4af0819e56f69915bd8330e4a | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-AT_1-Differentiating_AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 7.18e-06 | 186 | 237 | 8 | 4e94158db52df41d71e67b02b9895a358eebee0f | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.77e-06 | 188 | 237 | 8 | eea652bab161f19148a883e7e3fe2523b36b3cea | |
| ToppCell | Epithelial-ciliated_cell|World / Lineage, Cell type, age group and donor | 7.77e-06 | 188 | 237 | 8 | 61a459f3fe57e5728efc72637ff2edc2d343492b | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.77e-06 | 188 | 237 | 8 | 4d1e5f85342ae550086609d7680e32730b78b5d2 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_ASM_(13)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.77e-06 | 188 | 237 | 8 | f54b063025d80de631382bf5326bc40aab7f7d00 | |
| ToppCell | Control-Epithelial_cells|Control / group, cell type (main and fine annotations) | 7.77e-06 | 188 | 237 | 8 | 707ebf76cc6fb600b2f07793cf4ea9482c0de79d | |
| ToppCell | Control|World / Disease state, Lineage and Cell class | 8.07e-06 | 189 | 237 | 8 | fb8dddd3b901081c6bb9ed6f32dafc5cce5f30be | |
| ToppCell | RA-10._Endothelium_II|RA / Chamber and Cluster_Paper | 8.07e-06 | 189 | 237 | 8 | c81787a8c662db5d7814c583dd64562857629e81 | |
| ToppCell | Adult-Epithelial-ciliated_cell|Adult / Lineage, Cell type, age group and donor | 8.07e-06 | 189 | 237 | 8 | b679920f0993e917dd86da082113bfbd85ea1ca5 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.39e-06 | 190 | 237 | 8 | 8aea807a2bcf0b653b4de6202b6ecb0f0683cc2e | |
| ToppCell | Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Immature_INs|3.5_mon / Sample Type, Dataset, Time_group, and Cell type. | 8.39e-06 | 190 | 237 | 8 | 842760bfe0a52e67bad800efa7d99448a4a23ebb | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 8.39e-06 | 190 | 237 | 8 | e102622f05c7f3e1bd8b224ea159d57033793ee0 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 8.72e-06 | 191 | 237 | 8 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | COPD-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 8.72e-06 | 191 | 237 | 8 | ef16ad1c1cd2c0c0377957398c98775b62a81754 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|World / Lineage, Cell type, age group and donor | 8.72e-06 | 191 | 237 | 8 | d3733c8c4bda70c4390e5601fdda6188a64be944 | |
| ToppCell | human_hepatoblastoma-Tumor_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 9.06e-06 | 192 | 237 | 8 | 916fbec1c7ab7969bda711886ac88e877e30c280 | |
| ToppCell | renal_cortex_nuclei|World / Celltypes from Cells and Nuclei per compartment and clinical group | 9.06e-06 | 192 | 237 | 8 | e8cc4d08fcfceeab75a02558817e4ccd7dbafe3a | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.06e-06 | 192 | 237 | 8 | d0fb6885f023d55a2b7984c99db9c6463258f788 | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.41e-06 | 193 | 237 | 8 | 4aa976b596830b585e8d9c808d5072ed23d13a7c | |
| ToppCell | nucseq|World / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 9.41e-06 | 193 | 237 | 8 | 779276e775cb2492e8dd36436295a536084a6415 | |
| ToppCell | Control-Endothelial-Endothelial-Gen_Cap|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 9.41e-06 | 193 | 237 | 8 | e1d546165dcc2392f540162206852c4717d7306f | |
| ToppCell | human_hepatoblastoma-Tumor_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 9.41e-06 | 193 | 237 | 8 | 503a979328c68b096680b71359a26f02fafdff35 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Stem-like-NPC-like-NPC-like_neural-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.41e-06 | 193 | 237 | 8 | 088c8b1e968f5356502347eaabdc6b1b1d4befd0 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.41e-06 | 193 | 237 | 8 | bbdfda6665941cfa1965418bb91ef9ff43b1326f | |
| ToppCell | 5'-GW_trimst-1.5-LargeIntestine-Mesenchymal-myocytic-SMC_(PLPP2+)|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.41e-06 | 193 | 237 | 8 | 5578f7cb3ec68c9a38cc5304b618b81283024d5e | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 9.77e-06 | 194 | 237 | 8 | 67f5e2f05a8de2213ab80d5ea16fdee121684633 | |
| ToppCell | 3'-GW_trimst-1-LargeIntestine-Mesenchymal-myocytic|GW_trimst-1 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.77e-06 | 194 | 237 | 8 | 15060cc25baf49dd04d9c20499e28718610ef754 | |
| ToppCell | 5'-GW_trimst-2-SmallIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.77e-06 | 194 | 237 | 8 | d2bafd31bb8333f66b6c714944bceb2f1aa11740 | |
| ToppCell | control-Lymphoid-Treg|Lymphoid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 1.01e-05 | 195 | 237 | 8 | 66959ae839eb60a573da06bdd227090ebb5bb9ed | |
| ToppCell | PND28-Mesenchymal-Mesenchymal_myocytic|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.05e-05 | 196 | 237 | 8 | 4740ef6e428f1ccc81fc98c3b868afd38ce60535 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 1.05e-05 | 196 | 237 | 8 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Int-URO-Myeloid-CD14_Mono|Int-URO / Disease, Lineage and Cell Type | 1.05e-05 | 196 | 237 | 8 | e6a897c29404119fb40c29033d0198a866015bf8 | |
| Drug | Nsc687160 | 3.20e-10 | 18 | 234 | 7 | CID005459290 | |
| Drug | tolytoxin | 5.02e-10 | 19 | 234 | 7 | CID006440827 | |
| Drug | NSC312786 | 1.14e-09 | 21 | 234 | 7 | CID000329495 | |
| Drug | AC1L8NVR | 1.14e-09 | 21 | 234 | 7 | CID000384633 | |
| Drug | AC1L9EF8 | CHAF1B ACTBL2 ACTA1 ACTA2 ACTB ACTC1 BBS1 ACTG1 ACTG2 ADGRG2 | 8.41e-09 | 79 | 234 | 10 | CID000443315 |
| Drug | azaspiracid | 1.84e-08 | 30 | 234 | 7 | CID006451158 | |
| Drug | m2-19 | 2.68e-08 | 19 | 234 | 6 | CID000079129 | |
| Drug | AC1L1HS4 | 2.99e-08 | 32 | 234 | 7 | CID000004267 | |
| Drug | N,N'-p-phenylenedimaleimide | 4.70e-08 | 34 | 234 | 7 | CID000076765 | |
| Drug | 1,N6-ethenoadenosine 5'-diphosphate | 4.70e-08 | 34 | 234 | 7 | CID000001312 | |
| Drug | 3-methylhistidine | 8.87e-08 | 55 | 234 | 8 | CID000064969 | |
| Drug | epsilon-ATP | 1.85e-07 | 41 | 234 | 7 | CID000162262 | |
| Drug | D-myo-inositol 1,4-bisphosphate | 2.54e-07 | 86 | 234 | 9 | CID000000805 | |
| Drug | AC1L8FNU | 3.07e-07 | 44 | 234 | 7 | CID000425429 | |
| Drug | CID5288653 | 3.45e-07 | 28 | 234 | 6 | CID005288653 | |
| Drug | AC1L1GXW | 5.47e-07 | 94 | 234 | 9 | CID000003891 | |
| Drug | NpCaM | 5.70e-07 | 48 | 234 | 7 | CID000122259 | |
| Drug | AC1Q6LQU | 5.70e-07 | 48 | 234 | 7 | CID000072380 | |
| Drug | NSC3096 | 7.80e-07 | 98 | 234 | 9 | CID000002832 | |
| Drug | AC1NSKFN | 1.66e-06 | 36 | 234 | 6 | CID005311324 | |
| Drug | plakin | 2.05e-06 | 82 | 234 | 8 | CID000018752 | |
| Drug | dihydrocytochalasin B | 2.13e-06 | 58 | 234 | 7 | CID000003064 | |
| Drug | formamide | 2.69e-06 | 85 | 234 | 8 | CID000000713 | |
| Drug | AC1NSKHI | 3.01e-06 | 61 | 234 | 7 | CID005311358 | |
| Drug | bistheonellide A | 3.39e-06 | 11 | 234 | 4 | CID006441172 | |
| Drug | Viroisin | 3.39e-06 | 11 | 234 | 4 | CID000119538 | |
| Drug | oryzalin | 3.76e-06 | 63 | 234 | 7 | CID000029393 | |
| Drug | AC1L22RD | 4.51e-06 | 91 | 234 | 8 | CID000065183 | |
| Drug | C18:1n-7 | 4.89e-06 | 92 | 234 | 8 | CID000122325 | |
| Drug | BFDGE | 5.05e-06 | 12 | 234 | 4 | CID000091511 | |
| Drug | 5-IAF | 5.15e-06 | 66 | 234 | 7 | CID000123822 | |
| Drug | AC1L1ERT | 6.95e-06 | 69 | 234 | 7 | CID000002920 | |
| Drug | caged ATP | 7.66e-06 | 70 | 234 | 7 | CID000123806 | |
| Drug | NSC613009 | 8.22e-06 | 130 | 234 | 9 | CID000003800 | |
| Drug | pyrene | 8.75e-06 | 131 | 234 | 9 | CID000031423 | |
| Drug | kabiramide C | 1.00e-05 | 14 | 234 | 4 | CID005288658 | |
| Drug | AC1NRBPQ | 1.26e-05 | 137 | 234 | 9 | CID005288569 | |
| Drug | NSC106399 | 1.35e-05 | 51 | 234 | 6 | CID000002887 | |
| Drug | SIRIUS | 1.45e-05 | 77 | 234 | 7 | CID000091750 | |
| Drug | NSC60597 | 1.50e-05 | 140 | 234 | 9 | CID000003327 | |
| Drug | Ro-1724 | 1.84e-05 | 110 | 234 | 8 | CID000005087 | |
| Drug | aluminum fluoride | ACTBL2 ACTB ZIM2 ACTC1 ACTG1 ASAP1 PTPN3 AFF1 AFDN PLCB2 NUP153 DNM1L | 2.32e-05 | 268 | 234 | 12 | CID000002124 |
| Drug | blebbistatin | 2.70e-05 | 116 | 234 | 8 | CID003476986 | |
| Drug | foscarnet | 2.87e-05 | 190 | 234 | 10 | CID000003414 | |
| Drug | B0683 | 2.88e-05 | 117 | 234 | 8 | CID006398969 | |
| Drug | MAPS | MAPT ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 ATP6V0A4 EML1 | 3.00e-05 | 191 | 234 | 10 | CID000066161 |
| Drug | Pb m | 3.06e-05 | 118 | 234 | 8 | CID006327255 | |
| Drug | AC1OAGKW | 3.28e-05 | 193 | 234 | 10 | CID006857413 | |
| Drug | CaCl2 | 3.53e-05 | 156 | 234 | 9 | CID000024854 | |
| Drug | 5'IATR | 3.73e-05 | 19 | 234 | 4 | CID000074997 | |
| Drug | Nadolol [42200-33-9]; Up 200; 13uM; MCF7; HT_HG-U133A | 4.08e-05 | 198 | 234 | 10 | 3359_UP | |
| Drug | Caffeic acid [3331-39-5]; Up 200; 22.2uM; MCF7; HT_HG-U133A | 4.08e-05 | 198 | 234 | 10 | 5352_UP | |
| Drug | cnicin | 4.62e-05 | 92 | 234 | 7 | CID000091176 | |
| Drug | Methamphetamine | TTC39B NRG1 SP100 GRIPAP1 MAPT ATXN7L1 ACTB ACTC1 ACTG1 GON4L PFKFB2 EMSY TUFM ACOX3 RTKN2 APEX2 RAPGEF3 AHNAK BUB1B MTARC2 SPTY2D1 PPP1R9A TACC2 BTAF1 CHORDC1 TEF CDC42EP3 ZNF532 MACF1 LSP1 SMAD3 | 4.70e-05 | 1401 | 234 | 31 | ctd:D008694 |
| Drug | ATP betaS | 4.75e-05 | 162 | 234 | 9 | CID005311341 | |
| Drug | mDia | 4.95e-05 | 93 | 234 | 7 | CID000128346 | |
| Drug | AC1OAGGW | 5.04e-05 | 203 | 234 | 10 | CID006857364 | |
| Drug | 2-(1H-indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-ylthieno(3,2-d)pyrimidine | NRG1 SP100 HIF1A RB1CC1 ERBIN PXK BRD8 DLG2 ANKRD52 SFN BAZ2B ICE2 CHORDC1 JMJD1C FGFBP3 KDM7A CTSB | 5.43e-05 | 546 | 234 | 17 | ctd:C532162 |
| Drug | Mgamp-pnp | 5.67e-05 | 21 | 234 | 4 | CID005311323 | |
| Drug | manidipine | 5.68e-05 | 95 | 234 | 7 | CID000004008 | |
| Drug | microcystin-LR | 5.79e-05 | 129 | 234 | 8 | CID000445433 | |
| Drug | SF6847 | 6.09e-05 | 41 | 234 | 5 | CID000005614 | |
| Drug | AC1LADJ6 | 6.11e-05 | 130 | 234 | 8 | CID000486032 | |
| Drug | 5'-N-ethylcarboxamidoadenosine | 8.25e-05 | 174 | 234 | 9 | CID000104795 | |
| Drug | AC1MNW2N | 8.37e-05 | 70 | 234 | 6 | CID003359490 | |
| Drug | beryllium fluoride | 9.50e-05 | 103 | 234 | 7 | CID000024589 | |
| Drug | Nbd-Ph | 9.83e-05 | 24 | 234 | 4 | CID004682184 | |
| Drug | etheno-NAD | 1.01e-04 | 104 | 234 | 7 | CID005288160 | |
| Drug | L-Carnosine | 1.06e-04 | 73 | 234 | 6 | CID000009369 | |
| Drug | 0-to | 1.08e-04 | 141 | 234 | 8 | CID000002051 | |
| Drug | NSC350593 | ACTBL2 ACTA1 ACTA2 ACTB ACTC1 BBS1 ACTG1 ACTG2 ADA PLCB2 CD14 | 1.14e-04 | 269 | 234 | 11 | CID000004364 |
| Drug | C3H2N2O3S | 1.14e-04 | 74 | 234 | 6 | CID000448652 | |
| Drug | tetramethylrhodamine isothiocyanate | 1.19e-04 | 47 | 234 | 5 | CID004123009 | |
| Drug | AC1LD8HW | 1.23e-04 | 75 | 234 | 6 | CID000644061 | |
| Drug | thalidomide | CYP4B1 ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 IKZF5 PDZD2 | 1.37e-04 | 229 | 234 | 10 | CID000005426 |
| Drug | dihydrosphingosine | 1.38e-04 | 146 | 234 | 8 | CID000003126 | |
| Drug | Melphalan | ARHGAP24 PXK SCN8A SPTY2D1 ZNF438 MMS22L TACC2 REV3L CDC42EP3 RASL11B SMAD3 | 1.43e-04 | 276 | 234 | 11 | ctd:D008558 |
| Drug | AC1LCVPZ | 1.44e-04 | 110 | 234 | 7 | CID000656926 | |
| Drug | fluorescein isothiocyanate | 1.44e-04 | 147 | 234 | 8 | CID000018730 | |
| Drug | ML-9 | 1.44e-04 | 147 | 234 | 8 | CID000004217 | |
| Drug | bromodeoxyuridine | CDK18 NRG1 PSG6 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 BUB1B PLCB2 TEF CD14 | 1.50e-04 | 376 | 234 | 13 | CID000006035 |
| Drug | Clindamycin hydrochloride [21462-39-5]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 1.74e-04 | 192 | 234 | 9 | 2219_UP | |
| Drug | HU-211 | 1.79e-04 | 114 | 234 | 7 | CID000107778 | |
| Drug | Formyl | 1.87e-04 | 238 | 234 | 10 | CID000123370 | |
| Drug | Rp-cAMPS | 1.88e-04 | 194 | 234 | 9 | CID006426631 | |
| Drug | monochloramine | 1.93e-04 | 52 | 234 | 5 | CID000025423 | |
| Drug | Dobutamine hydrochloride [49745-95-1]; Up 200; 11.8uM; MCF7; HT_HG-U133A | 1.96e-04 | 195 | 234 | 9 | 5386_UP | |
| Drug | Alfaxalone [23930-19-0]; Down 200; 12uM; HL60; HT_HG-U133A | 1.96e-04 | 195 | 234 | 9 | 3135_DN | |
| Drug | 1tjp | 2.00e-04 | 116 | 234 | 7 | CID005459371 | |
| Drug | Miconazole [22916-47-8]; Down 200; 9.6uM; PC3; HT_HG-U133A | 2.03e-04 | 196 | 234 | 9 | 6615_DN | |
| Drug | DFMO | 2.08e-04 | 155 | 234 | 8 | CID000003009 | |
| Drug | troglitazone; Up 200; 10uM; MCF7; HT_HG-U133A | 2.19e-04 | 198 | 234 | 9 | 5592_UP | |
| Drug | Myricetin [529-44-2]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 2.19e-04 | 198 | 234 | 9 | 3270_UP | |
| Drug | Sulfasalazine [599-79-1]; Down 200; 10uM; MCF7; HT_HG-U133A | 2.19e-04 | 198 | 234 | 9 | 2882_DN | |
| Drug | Erythromycin [114-07-8]; Down 200; 5.4uM; HL60; HG-U133A | 2.19e-04 | 198 | 234 | 9 | 2010_DN | |
| Drug | TCNB | 2.34e-04 | 119 | 234 | 7 | CID000008330 | |
| Drug | D-myo-inositol-1,4,5-triphosphate | HIP1 INPP5K ACTBL2 ACTA1 ACTA2 ACTB ACTC1 ACTG1 ACTG2 PTPN3 PRR14 RAPGEF3 PLCB2 ITPKC UBXN11 DGKI | 2.80e-04 | 568 | 234 | 16 | CID000000806 |
| Disease | Moyamoya disease (implicated_via_orthology) | 1.09e-14 | 8 | 225 | 7 | DOID:13099 (implicated_via_orthology) | |
| Disease | autosomal dominant nonsyndromic deafness 20 (implicated_via_orthology) | 1.09e-14 | 8 | 225 | 7 | DOID:0110550 (implicated_via_orthology) | |
| Disease | Baraitser-Winter syndrome 1 (implicated_via_orthology) | 1.09e-14 | 8 | 225 | 7 | DOID:0081112 (implicated_via_orthology) | |
| Disease | thoracic aortic aneurysm (implicated_via_orthology) | 1.09e-14 | 8 | 225 | 7 | DOID:14004 (implicated_via_orthology) | |
| Disease | intestinal atresia (implicated_via_orthology) | 1.61e-13 | 10 | 225 | 7 | DOID:10486 (implicated_via_orthology) | |
| Disease | patent ductus arteriosus (implicated_via_orthology) | 1.61e-13 | 10 | 225 | 7 | DOID:13832 (implicated_via_orthology) | |
| Disease | cortical surface area measurement | ZHX3 MAPT DAPK1 TUFM FOCAD ARHGAP31 TOX3 AFF1 ZNF438 BAZ2B MED13L TEF CDC42EP3 STRIP1 NHSL1 ZNF106 KIAA0825 ADAMTS7 CEP112 DGKI MACF1 RASL11B EML1 FAM124B PDZD2 DNAH11 | 1.37e-05 | 1345 | 225 | 26 | EFO_0010736 |
| Disease | cortical thickness | ZHX3 MAPT RABGAP1 PXK TOX3 AFF1 DLEC1 ZNF438 FSD2 TACC2 CDC42EP3 JMJD1C NHSL1 ZNF106 KIAA0825 ADAMTS7 CEP112 DGKI MACF1 RASL11B EML1 AGBL2 PDZD2 | 1.58e-05 | 1113 | 225 | 23 | EFO_0004840 |
| Disease | Baraitser-Winter syndrome | 5.79e-05 | 2 | 225 | 2 | cv:C1853623 | |
| Disease | Moyamoya disease 1 | 5.79e-05 | 2 | 225 | 2 | C2931384 | |
| Disease | Iris Coloboma with Ptosis, Hypertelorism, and Mental Retardation | 5.79e-05 | 2 | 225 | 2 | C1855722 | |
| Disease | Fryns-Aftimos Syndrome | 5.79e-05 | 2 | 225 | 2 | C1853623 | |
| Disease | Multiple gastrointestinal atresias (disorder) | 5.79e-05 | 2 | 225 | 2 | C0220744 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Positive | 6.84e-05 | 131 | 225 | 7 | C4704862 | |
| Disease | Polyarthritis, Juvenile, Rheumatoid Factor Negative | 6.84e-05 | 131 | 225 | 7 | C4552091 | |
| Disease | Juvenile arthritis | 6.84e-05 | 131 | 225 | 7 | C3495559 | |
| Disease | Juvenile psoriatic arthritis | 6.84e-05 | 131 | 225 | 7 | C3714758 | |
| Disease | cerebral cavernous malformation (implicated_via_orthology) | 6.90e-05 | 11 | 225 | 3 | DOID:0060669 (implicated_via_orthology) | |
| Disease | waist-hip ratio | ZHX3 MAPT ATXN7L1 DAG1 C8orf34 RTKN2 DGLUCY RAPGEF3 AHNAK SCN4A DLG2 LUZP2 DLEC1 AP3D1 DMXL2 MMS22L IQCN CDC42EP3 JMJD1C SETBP1 GPCPD1 FAM124B SMAD3 | 6.98e-05 | 1226 | 225 | 23 | EFO_0004343 |
| Disease | neuroimaging measurement | ZHX3 MAPT PFKFB2 TOX3 AFF1 DLG2 ZNF438 TACC2 REV3L POM121C CDC42EP3 JMJD1C NHSL1 ZNF106 RHPN2 CEP112 DGKI MACF1 RASL11B EML1 DNAH11 | 7.71e-05 | 1069 | 225 | 21 | EFO_0004346 |
| Disease | Juvenile-Onset Still Disease | 8.27e-05 | 135 | 225 | 7 | C0087031 | |
| Disease | brain measurement, neuroimaging measurement | ZHX3 RABGAP1 TOX3 DLG2 ZNF438 CDC42EP3 NHSL1 RHPN2 CEP112 DGKI MACF1 RASL11B EML1 DNAH11 | 9.29e-05 | 550 | 225 | 14 | EFO_0004346, EFO_0004464 |
| Disease | protein-glutamine gamma-glutamyltransferase e measurement | 9.57e-05 | 60 | 225 | 5 | EFO_0020690 | |
| Disease | Malignant neoplasm of breast | NRG1 HIF1A INPP5K ACTA2 RB1CC1 FSCB EMSY ALKBH8 TOX3 AFF1 DLEC1 BCAR3 ZNF438 TACC2 NUP214 ATF2 ZNF532 SETBP1 MACF1 LSP1 | 2.32e-04 | 1074 | 225 | 20 | C0006142 |
| Disease | sleep duration, high density lipoprotein cholesterol measurement | 3.41e-04 | 121 | 225 | 6 | EFO_0004612, EFO_0005271 | |
| Disease | Cerebellar Hemiataxia | 3.44e-04 | 4 | 225 | 2 | C0750994 | |
| Disease | Cerebellar Dysmetria | 3.44e-04 | 4 | 225 | 2 | C0234162 | |
| Disease | Hypermetria (finding) | 3.44e-04 | 4 | 225 | 2 | C3668822 | |
| Disease | Adiadochokinesis | 3.44e-04 | 4 | 225 | 2 | C0234357 | |
| Disease | QRS duration | 5.02e-04 | 298 | 225 | 9 | EFO_0005055 | |
| Disease | Cerebellar Ataxia | 5.70e-04 | 5 | 225 | 2 | C0007758 | |
| Disease | Moyamoya disease (is_implicated_in) | 5.70e-04 | 5 | 225 | 2 | DOID:13099 (is_implicated_in) | |
| Disease | Alzheimer disease, educational attainment | 6.52e-04 | 247 | 225 | 8 | EFO_0011015, MONDO_0004975 | |
| Disease | creatinine measurement | CDK18 NRG1 CHAF1B HIF1A ACTG2 PFKFB2 PTPN3 DLEC1 BCAR3 A1CF ICE2 FSD2 BTAF1 CHORDC1 ADAMTS7 SETBP1 CTSB SMAD3 | 6.67e-04 | 995 | 225 | 18 | EFO_0004518 |
| Disease | Squamous cell carcinoma of esophagus | 8.19e-04 | 95 | 225 | 5 | C0279626 | |
| Disease | omega-6 polyunsaturated fatty acid measurement | 8.24e-04 | 197 | 225 | 7 | EFO_0005680 | |
| Disease | Fibroid Tumor | 8.51e-04 | 6 | 225 | 2 | C0023267 | |
| Disease | neurofilament light chain measurement | 9.47e-04 | 57 | 225 | 4 | EFO_0009178 | |
| Disease | primary aldosteronism | 9.99e-04 | 26 | 225 | 3 | MONDO_0001422 | |
| Disease | inflammatory biomarker measurement | 9.99e-04 | 26 | 225 | 3 | EFO_0004872 | |
| Disease | Adenoid Cystic Carcinoma | 1.03e-03 | 100 | 225 | 5 | C0010606 | |
| Disease | cholesteryl esters:total lipids ratio, intermediate density lipoprotein measurement | 1.18e-03 | 103 | 225 | 5 | EFO_0008595, EFO_0020944 | |
| Disease | Uterine Fibroids | 1.19e-03 | 7 | 225 | 2 | C0042133 | |
| Disease | Uveoretinal Coloboma | 1.19e-03 | 7 | 225 | 2 | C4554007 | |
| Disease | stimulant use measurement | 1.24e-03 | 28 | 225 | 3 | EFO_0600076 | |
| Disease | body fat percentage | HIVEP1 ADA TUFM DMXL2 MMS22L IQCN POM121C SETBP1 MACF1 AGBL2 SMAD3 | 1.40e-03 | 488 | 225 | 11 | EFO_0007800 |
| Disease | nemaline myopathy (implicated_via_orthology) | 1.57e-03 | 8 | 225 | 2 | DOID:3191 (implicated_via_orthology) | |
| Disease | muscular dystrophy-dystroglycanopathy type B1 (implicated_via_orthology) | 1.57e-03 | 8 | 225 | 2 | DOID:0050588 (implicated_via_orthology) | |
| Disease | Dickkopf-related protein 4 measurement | 1.57e-03 | 8 | 225 | 2 | EFO_0008110 | |
| Disease | Age-related nuclear cataract | 1.68e-03 | 31 | 225 | 3 | HP_0011142 | |
| Disease | phospholipids:total lipids ratio, intermediate density lipoprotein measurement | 1.73e-03 | 67 | 225 | 4 | EFO_0008595, EFO_0020946 | |
| Disease | triglyceride measurement, low density lipoprotein cholesterol measurement | 1.77e-03 | 166 | 225 | 6 | EFO_0004530, EFO_0004611 | |
| Disease | serum gamma-glutamyl transferase measurement | CDK18 ACTG1 GON4L WDFY2 EMSY PTPN3 POM121 AHNAK AFF1 A1CF ICE2 POM121C JMJD1C RHPN2 HSPB7 CD276 | 1.84e-03 | 914 | 225 | 16 | EFO_0004532 |
| Disease | cortical surface area measurement, neuroimaging measurement | 1.86e-03 | 227 | 225 | 7 | EFO_0004346, EFO_0010736 | |
| Disease | protein CREG1 measurement | 2.01e-03 | 9 | 225 | 2 | EFO_0801937 | |
| Disease | Congenital ocular coloboma (disorder) | 2.01e-03 | 9 | 225 | 2 | C0009363 | |
| Disease | forced expiratory volume, response to bronchodilator | SP100 ASAP1 AHNAK DLG2 MS4A14 MMS22L DNM1L ADAMTS7 CEP112 TTC29 | 2.33e-03 | 445 | 225 | 10 | EFO_0004314, GO_0097366 |
| Disease | pulse pressure measurement | NRG1 BRPF3 HIP1 ARHGAP24 ACTA2 RABGAP1 DHX8 ASCC2 DLEC1 FERMT2 AP3D1 STK25 ZNF438 MXRA5 RNF213 MED13L LSP1 EML1 AGBL2 CNOT1 SMAD3 | 2.36e-03 | 1392 | 225 | 21 | EFO_0005763 |
| Disease | generalized epilepsy with febrile seizures plus 2 (implicated_via_orthology) | 2.50e-03 | 10 | 225 | 2 | DOID:0111294 (implicated_via_orthology) | |
| Disease | Dravet syndrome (implicated_via_orthology) | 2.50e-03 | 10 | 225 | 2 | DOID:0080422 (implicated_via_orthology) | |
| Disease | thiamine measurement | 2.50e-03 | 10 | 225 | 2 | EFO_0010540 | |
| Disease | fetuin-B measurement | 2.50e-03 | 10 | 225 | 2 | EFO_0008128 | |
| Disease | Congenital neurologic anomalies | 2.50e-03 | 10 | 225 | 2 | C0497552 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 2.50e-03 | 10 | 225 | 2 | cv:C4707243 | |
| Disease | Cranioschisis | 2.50e-03 | 10 | 225 | 2 | C0265541 | |
| Disease | basophil percentage of leukocytes | 2.73e-03 | 243 | 225 | 7 | EFO_0007992 | |
| Disease | sleep latency | 2.81e-03 | 37 | 225 | 3 | EFO_0005280 | |
| Disease | Neoplasm Invasiveness | 2.96e-03 | 184 | 225 | 6 | C0027626 | |
| Disease | urate measurement, bone density | CHAF1B ARHGAP24 RC3H1 ERBIN DLG2 LUZP2 SLC38A3 NUP153 BAZ2B MAML2 PDZD2 DNAH11 | 3.01e-03 | 619 | 225 | 12 | EFO_0003923, EFO_0004531 |
| Disease | guanosine diphosphate measurement | 3.04e-03 | 11 | 225 | 2 | EFO_0010494 | |
| Disease | gastrin-releasing peptide measurement | 3.04e-03 | 11 | 225 | 2 | EFO_0022000 | |
| Disease | Cleft palate, tobacco smoke exposure measurement, cleft lip, parental genotype effect measurement | 3.04e-03 | 11 | 225 | 2 | EFO_0003959, EFO_0005939, EFO_0009115, HP_0000175 | |
| Disease | red blood cell density measurement | NRG1 HIVEP1 MAPT PXK TUFM FOCAD PTPN3 AFF1 AFDN AP3D1 RFC1 JMJD1C ZNF106 TAF3 MAML2 | 3.26e-03 | 880 | 225 | 15 | EFO_0007978 |
| Disease | ovarian carcinoma | 3.38e-03 | 321 | 225 | 8 | EFO_0001075 | |
| Disease | generalized epilepsy with febrile seizures plus (implicated_via_orthology) | 3.63e-03 | 12 | 225 | 2 | DOID:0060170 (implicated_via_orthology) | |
| Disease | dementia (is_implicated_in) | 3.63e-03 | 12 | 225 | 2 | DOID:1307 (is_implicated_in) | |
| Disease | basophil percentage of granulocytes | 3.78e-03 | 83 | 225 | 4 | EFO_0007995 | |
| Disease | very low density lipoprotein cholesterol measurement | 3.95e-03 | 260 | 225 | 7 | EFO_0008317 | |
| Disease | DEAFNESS, AUTOSOMAL RECESSIVE (disorder) | 4.27e-03 | 13 | 225 | 2 | C1846647 | |
| Disease | undecenoylcarnitine (C11:1) measurement | 4.27e-03 | 13 | 225 | 2 | EFO_0800588 | |
| Disease | smoking status measurement, ulcerative colitis | 4.27e-03 | 13 | 225 | 2 | EFO_0000729, EFO_0006527 | |
| Disease | skin melanoma (is_marker_for) | 4.27e-03 | 13 | 225 | 2 | DOID:8923 (is_marker_for) | |
| Disease | memory performance | 4.37e-03 | 409 | 225 | 9 | EFO_0004874 | |
| Disease | cholelithiasis | 4.66e-03 | 88 | 225 | 4 | EFO_0004799 | |
| Disease | Malignant neoplasm of salivary gland | 4.90e-03 | 45 | 225 | 3 | C0220636 | |
| Disease | PR interval | ARHGAP24 DAG1 AFF1 DLEC1 FERMT2 ARRDC5 UBXN11 MACF1 CNOT1 DNAH11 | 4.94e-03 | 495 | 225 | 10 | EFO_0004462 |
| Disease | severe combined immunodeficiency (is_implicated_in) | 4.96e-03 | 14 | 225 | 2 | DOID:627 (is_implicated_in) | |
| Disease | cholesterol:total lipids ratio, low density lipoprotein cholesterol measurement | 5.04e-03 | 144 | 225 | 5 | EFO_0004611, EFO_0020943 | |
| Disease | Salivary Gland Neoplasms | 5.54e-03 | 47 | 225 | 3 | C0036095 | |
| Disease | Anilide use measurement | 5.69e-03 | 15 | 225 | 2 | EFO_0009938 | |
| Disease | triglycerides:total lipids ratio, low density lipoprotein cholesterol measurement | 5.97e-03 | 150 | 225 | 5 | EFO_0004611, EFO_0020947 | |
| Disease | brain volume measurement | MAPT GON4L SCN8A DLG2 MMS22L CDC42EP3 ZNF106 RHPN2 EML1 AGBL2 DNAH11 | 6.26e-03 | 595 | 225 | 11 | EFO_0006930 |
| Disease | Blood Platelet Disorders | 6.47e-03 | 16 | 225 | 2 | C0005818 | |
| Disease | peanut allergy measurement | 6.47e-03 | 16 | 225 | 2 | EFO_0007017 | |
| Disease | Dystonia, Limb | 7.30e-03 | 17 | 225 | 2 | C0751093 | |
| Disease | Dystonia, Diurnal | 7.30e-03 | 17 | 225 | 2 | C0393610 | |
| Disease | rhinitis | 7.30e-03 | 17 | 225 | 2 | EFO_0008521 | |
| Disease | Moyamoya Disease | 7.30e-03 | 17 | 225 | 2 | C0026654 | |
| Disease | Mammary Carcinoma, Human | 7.35e-03 | 525 | 225 | 10 | C4704874 | |
| Disease | Mammary Neoplasms, Human | 7.35e-03 | 525 | 225 | 10 | C1257931 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| RTSPIKMPLVPEVLI | 491 | Q8N1M1 | |
| MSLKDLPSDPERLLP | 626 | O60566 | |
| PLTAQQMKPEKPSTL | 1456 | P55196 | |
| SLPPEMRIPKNGIEK | 431 | P08243 | |
| QSLGPIMLTKIPLEP | 176 | Q14264 | |
| SRPLKPLSPLRAQDM | 486 | O60825 | |
| EMRPPLIETSINQPK | 611 | Q96RT1 | |
| KPENIMLLDRNVPKP | 141 | P53355 | |
| LLNVIGMDKPLTLPD | 46 | P00813 | |
| GTKELPVPLMTLTPQ | 371 | Q9N2J8 | |
| PLPPNIKDRLIKIMS | 31 | Q8IY45 | |
| PKPPQRVMFTEDLKL | 66 | P07858 | |
| LLAEEKSKPIPIMPA | 601 | O00429 | |
| FIVQIRDPKTLLPMP | 226 | O15254 | |
| LTPMNPVTLKPQGIK | 431 | Q9NQ94 | |
| PSPQPDVTMLSRLLK | 21 | P78537 | |
| DISKKEMPPTNPIRL | 156 | P31947 | |
| KSPDTSLLLPDLLPM | 796 | Q2M2I8 | |
| VPLPAPEMTVKQERL | 471 | Q9H0E9 | |
| ALAPSTMKIKIIAPP | 321 | P68133 | |
| PPENKPLETAMLKRA | 526 | O75815 | |
| LKTIPMSTKPANELP | 761 | Q8IZF6 | |
| LAPSTMKIKIIAPPE | 321 | Q562R1 | |
| MTVTLDPPQKLPDLF | 456 | Q9Y672 | |
| KELRPQALPPGLMVV | 126 | Q96BT7 | |
| QKLQMESPDLPKPLS | 111 | Q07002 | |
| LKIPRAVPVLKMDAP | 171 | P51813 | |
| MCLADQKPLPELPRI | 1066 | Q9UIF8 | |
| APSTMKIKIIAPPER | 321 | P60709 | |
| APSTMKIKIIAPPER | 321 | P63261 | |
| LDREMKPDPTPLLTS | 521 | Q9H1I8 | |
| SPPDMLAPLAQRLLK | 411 | Q8IZP9 | |
| ALAPSTMKIKIIAPP | 321 | P62736 | |
| LMTKLITETPDQPIP | 111 | Q49A92 | |
| GIPLKEKPVLNMRTP | 381 | Q13112 | |
| LRQKPIPVSLMTPKF | 221 | Q8N8E3 | |
| QSPAPIKQLEDLPMS | 1406 | Q8IYW2 | |
| AQMILLPPEIVFKPS | 946 | Q96DT5 | |
| PALIIDPKMPREGLL | 1091 | Q9ULD4 | |
| PKISMPDIDLNLKGP | 3541 | Q09666 | |
| PKISMPDIDLNLKGP | 3871 | Q09666 | |
| LAPSTMKIKIIAPPE | 321 | P63267 | |
| KMPLDLSPLATPIIR | 106 | P15336 | |
| SKPSMTLEPNKDLRP | 361 | Q5ZPR3 | |
| SVPMPLPTVLLDRKI | 481 | Q8TDJ6 | |
| ELPSLPLMSALMTPK | 411 | Q9UBZ4 | |
| LALILSTMKPFPPKD | 1011 | Q8NB46 | |
| KLRDILSPDMISPPL | 21 | Q9UKI2 | |
| VPVQIPIMKSPLDKI | 416 | Q96NX9 | |
| PIMKSPLDKIQLTPG | 421 | Q96NX9 | |
| PPPLKVNLVVMLAEL | 296 | Q9P1Y5 | |
| KILLTEPPMNPTKNR | 106 | P61160 | |
| STPPLIKPVLMSKSV | 236 | Q9ULK2 | |
| PIAPLPEMKVRDSSL | 1296 | Q9UKP4 | |
| EQPLDPSLIPKLMSF | 211 | Q76M96 | |
| MPPFPERESSILAKL | 601 | O94973 | |
| QIDLSVPLKVPGLPM | 706 | O14617 | |
| MLETKVFPRPVLPSL | 366 | Q6P387 | |
| ANSPLKIPKMEVLSP | 11 | Q6P1R3 | |
| IMAQLEERKVISPPP | 761 | Q5TC82 | |
| RKTLVSMPPLPGLDL | 166 | P48382 | |
| PEENRLLSPPIMVNK | 176 | Q9H0B3 | |
| SMSLLLRKPQTPPTV | 626 | Q5JSJ4 | |
| LEQLMKDPLRPFVPA | 441 | Q96DU7 | |
| TELDPDAPIRQKMPL | 321 | P57740 | |
| QKMPLVVSRINPESP | 531 | P26045 | |
| DPPATPMQKLISLVR | 626 | Q17RG1 | |
| MLKDPFVRSKLISPP | 1426 | Q6DT37 | |
| QSPALPPRLKEMKSQ | 31 | Q02297 | |
| KEMILCDRPPAIPKT | 76 | Q8TDY2 | |
| LVGLQKPEMSLPVKP | 111 | Q9Y3P9 | |
| MTPPKLRASLSPSLL | 1 | Q8TAT2 | |
| MVPKLDDLGLRLPSP | 161 | Q6ZMT4 | |
| EMTLKNPERPSPIQL | 1781 | Q71F56 | |
| SMNSSEEKPLPIRPL | 1161 | Q8IV33 | |
| EIPPNIPSVQLKMDR | 116 | Q5H9T9 | |
| LPAPMLSAIQKSLPL | 986 | Q6ZRQ5 | |
| INLAMSPLPTAETPK | 446 | Q16665 | |
| PQPPMSVVKSIELVL | 11 | A6NEK1 | |
| MELLPKEKFVSRPPT | 491 | Q15652 | |
| SSSEMKAPVLPEPIL | 111 | Q5U5R9 | |
| PSSSMPLILQEEKAP | 811 | Q14118 | |
| TKSLPLPTPEEKMRQ | 196 | Q5SYE7 | |
| ADLKQLPELNPPVLM | 176 | Q96I76 | |
| EQPLMPARSPDSKIQ | 1821 | O15018 | |
| MPPDLLLQVLKQLDP | 141 | Q8NA70 | |
| NRPPVMALAIPIAVK | 121 | Q14D04 | |
| LPLRPLIKMPCLEAF | 66 | P0DUQ1 | |
| TISDEKTLPPAPVLM | 376 | P35658 | |
| KTLPPAPVLMLLSTD | 381 | P35658 | |
| ACRIILPPEKELAMP | 386 | P49411 | |
| LINLSPPSMVVQKPD | 196 | Q9H5V7 | |
| QSLEDLPKKMAPLQP | 446 | Q96M63 | |
| LPKKMAPLQPPDTLE | 451 | Q96M63 | |
| LIPPPNKDAIEMASR | 921 | Q9UPN3 | |
| ELPTMPKDSPQQLEL | 376 | P48551 | |
| TNPLLESLKKMQTPP | 571 | A8CG34 | |
| LLESLKKMQTPPSLP | 181 | A6NF01 | |
| STPRPSLPMEKIVIK | 351 | Q8IZL2 | |
| PLLESLKKMQTPPSL | 596 | Q96HA1 | |
| VIRPPLMLEKLVCQP | 451 | Q3KR16 | |
| SRALPAQDPPMEKAL | 31 | Q9UBY9 | |
| LEVMNPPPKKIRLQE | 61 | Q3MIT2 | |
| DVSRSPPLMVKKNPA | 411 | Q8N264 | |
| MTDLTSSIPKPLLPV | 16 | Q9NR50 | |
| SVVLEALVPLKTPMP | 176 | Q8IV32 | |
| TLRATPVIKPIMLPL | 861 | Q711Q0 | |
| LKITGTMPPLPLEAT | 126 | P08571 | |
| LSLKQLPPGMSVDPK | 186 | Q9H5Z6 | |
| TISLPKPIMQPTEAE | 126 | A1L1A6 | |
| LKPISRKVPELPLMN | 656 | Q659A1 | |
| QPFPSLKMVLESLPE | 436 | Q9NPB8 | |
| LAPTDNPPKLSALEM | 126 | Q99704 | |
| PEKLNPIIKPLMETI | 871 | O14981 | |
| KPENIMLLDKNIPIP | 151 | Q9UIK4 | |
| IKPISSPLMKPLLVF | 366 | O75912 | |
| SPLMKPLLVFVNPKS | 371 | O75912 | |
| MEPTFVQVPTLKKPL | 81 | Q8ND61 | |
| VPPSLDPSLTLKDRM | 1931 | O75417 | |
| ELKPLVSAPLIVLMP | 321 | Q9BT40 | |
| LLSSAPVPKVMLPSL | 1091 | Q3T8J9 | |
| LSEPPQPLARKDLME | 716 | Q5VT06 | |
| TPLDPSMATLILPKN | 826 | Q5U5Z8 | |
| MKDLPPKPQLGDLLA | 986 | Q9ULH1 | |
| NITSLKMPPLVSPQD | 56 | A0A1B0GTR0 | |
| RAPDMDQLVLPSKQP | 126 | Q969Z3 | |
| MLLPPRNIASKLPDA | 236 | Q86TE4 | |
| LPPTLEKKPSENMSI | 251 | Q96JA4 | |
| PERPKQEMLLSLKPS | 56 | P33241 | |
| AVEESISMKPLPPKL | 971 | Q9ULL0 | |
| FSLDPSRLPIKMPQL | 476 | P13584 | |
| PIAIFIKPRSLEPLM | 791 | Q15700 | |
| LFPPKPKDTLMISRT | 121 | P01859 | |
| VAKDRQLPTLMAQPP | 1026 | Q7Z589 | |
| PTKARPLMQTLPLRT | 81 | O00423 | |
| LSRLKNQMAEPLPPD | 276 | A8MQT2 | |
| PLVVTMRPIPKDKLE | 161 | Q7Z3D6 | |
| PITSPEILAKMFKPQ | 226 | Q96AC1 | |
| PTVLAPMPLAEVELK | 181 | Q4V328 | |
| PLEALLGSNKEPMLP | 46 | Q8IZY5 | |
| LKGPLVMTESPLPAL | 71 | Q8NFJ9 | |
| TSLPNMPPALLKTVR | 1146 | Q9Y238 | |
| LKLTIELPKPTTMPE | 2636 | Q6ZTR5 | |
| SVPPSLLKVVMKPIA | 1381 | Q5VW36 | |
| LRLIQTMRPPAKPST | 86 | Q14562 | |
| LDLPSLSKRMPSQPL | 316 | Q5VUJ6 | |
| PKSPSFPIIQDSMLK | 181 | Q2NL67 | |
| LPLPDVMVLAQPTKI | 81 | Q8TC56 | |
| MSPRKPPLFLTKEAT | 411 | Q8IZC4 | |
| TSLIPRPKSPNMQDL | 216 | Q9BPW5 | |
| LSSINTQKIPPMLSP | 216 | Q5VWG9 | |
| AMLPSLLPVLPEKLF | 676 | Q5VWG9 | |
| PELLISGMEKPLPLR | 361 | Q86WV6 | |
| KTVATMLLTPLAPAP | 141 | Q8NA92 | |
| MPTEKEPARSTPKIL | 456 | Q99624 | |
| GPIKPEKILESSIPM | 536 | Q9H7E2 | |
| MLPLPISKERALLPG | 101 | Q8N8N0 | |
| PNKIKLITLDLPMVP | 1656 | P35499 | |
| PVMPSLDELNPKSTV | 176 | Q9P0V3 | |
| DSNLMIRLPDRPLKP | 291 | Q6IEE7 | |
| NSAPPKPMSLKIERI | 161 | Q8TDR4 | |
| EGLKIPPPAMNEIIL | 791 | P35251 | |
| KDIDPFPQMATLLPL | 536 | Q8NE09 | |
| ILKTVMIPGPQLKPE | 276 | Q9BRJ2 | |
| RSDPVTLNLLPKLPM | 226 | Q00889 | |
| IPPLTQPFMLEKDIL | 306 | Q5VZ19 | |
| LEGSPAMLPVQPAKL | 56 | O95744 | |
| MTAPSPPIIKTKEIR | 466 | A1L4K1 | |
| PSPPMKLELKIAISE | 276 | Q9BWN1 | |
| KKLLPNMLSPDPREL | 1271 | Q96Q15 | |
| SSMKQVPNPLPKVLS | 6 | O00291 | |
| PLLTVATALMLPVKP | 11 | Q6UWY2 | |
| LPLRPLIKMPCLETF | 66 | A6NGN4 | |
| PLLLMNPEAGKPSDL | 236 | O14802 | |
| MQKTPIILSKPPAER | 61 | Q9H0W8 | |
| SMKAEKRSILGLPPL | 306 | Q5VSL9 | |
| LNRMAPVLPSVLKLP | 76 | Q9NZE8 | |
| LGTPLTPPKMKLNET | 691 | Q8TBC3 | |
| PLVLKKLMENPPREA | 36 | Q10587 | |
| LPKDIKMISPDLPFL | 721 | Q75T13 | |
| PCKPLAFILIPTMAI | 851 | Q75T13 | |
| LPLRPLIKMPCLEAF | 66 | A3QJZ7 | |
| RPLAEGLIKSPKPLM | 21 | Q9H093 | |
| KSAPPPMNFTDLLRL | 161 | Q68D10 | |
| MTDALLPAAPQPLEK | 1 | Q8IUC4 | |
| MRVLFLIPKNSPPTL | 221 | O00506 | |
| LTPVPTKMQSLLEPS | 291 | O94993 | |
| PSMIPIEKAQGPILL | 306 | Q8N9L9 | |
| ALAPSTMKIKIIAPP | 321 | P68032 | |
| PPPQSLMVKITLDLL | 756 | P51825 | |
| IKRPSPDEPMTNLEL | 106 | Q9UHD1 | |
| MLKPTLLTPSQLKSP | 96 | Q32M92 | |
| RMTVPKQTQTPDLLP | 286 | Q9ULV3 | |
| RLPDPFTPNLKVDML | 2141 | A5YKK6 | |
| MLKQTPVLPPTITDQ | 376 | Q92759 | |
| PIKDELLPVMSLPSS | 261 | Q6DJT9 | |
| LPLRPLIKMPCLEAF | 66 | O60810 | |
| DSPKMPLKTLHPLLE | 2851 | Q63HN8 | |
| RLALAKLSPPVIPFM | 801 | O95398 | |
| ILKPVPADQMIVSPS | 681 | Q9HCE3 | |
| GKLMPAPLLSLPEDK | 701 | Q9H9J4 | |
| QPVTDPLLTPMEKAS | 196 | Q5TAP6 | |
| LIFNPRAKPSELMPK | 726 | Q12768 | |
| SLPAPVKLILPALEM | 526 | Q5VTQ0 | |
| MAAEIQPKPLTRKPI | 1 | Q96P53 | |
| NILKPLMSPPSREEI | 1876 | O60673 | |
| MSSILPFTPPIVKRL | 1 | P84022 | |
| TQPPKMKEIPVGLRL | 56 | Q8N7X2 | |
| LPLRPLIKMPCLEAF | 66 | P0DUQ2 | |
| NPMRVLLKIAKSDPP | 241 | O94804 | |
| LKVLMENKFLPEPPS | 666 | P23497 | |
| NKTLDPLLMSEPKPR | 236 | Q6GPH4 | |
| LPLRPLIKMPCLEAF | 66 | O60813 | |
| LSLPLPPKKLIGNMD | 71 | Q7Z7A4 | |
| VPKPNTIELIAMDLP | 1821 | Q9UQD0 | |
| AKSRLQTAPVPMPDL | 556 | P10636 | |
| LEKSPLKPMAPIPQD | 266 | O95359 | |
| MPDLRRKKPLPLVSD | 416 | O14795 | |
| PIMKSLTLPALSLPM | 231 | Q2M1Z3 | |
| QQSLPRSIAPKPLTM | 376 | O15405 | |
| EMEVPVLPKISLPIT | 466 | P49790 | |
| LMPGILKQPSLTLEL | 1291 | Q86X10 | |
| MSLLNPVLLPPKVKA | 1 | Q00722 | |
| MLLTEPLEKFPLKPG | 431 | Q00722 | |
| LTPITMNDPKTLTPE | 266 | Q9NZV7 | |
| LEKSPLTPLPREMIT | 81 | Q9HBG4 | |
| PLPMTRPKLTALARQ | 6 | Q8NA56 | |
| EKKMPPLPVTLALGA | 276 | Q969M1 | |
| VKLRPSDPTVPLMAA | 441 | Q9ULT0 | |
| PLNKMTAISPEPQTL | 6 | Q8TF39 | |
| EGQLLPPKLLTMPRL | 591 | Q8TEQ8 | |
| KKVEMQRSLPGSLLP | 2386 | Q9BXT5 | |
| DFRKIDLKPLPPMTN | 931 | Q5TAX3 | |
| ELKTMPNLQPISALP | 801 | Q9Y6X0 | |
| PTAKALPKVMIPLSS | 291 | Q9H4I2 | |
| LSELLPLPLPMQTTQ | 1116 | Q69YN4 | |
| IQKPRMSLPENLKLP | 106 | Q7Z4V0 | |
| EHTPNKMPSLKSPLL | 441 | Q9H2Y7 | |
| LPGQMRPPLATKTLE | 731 | P15822 | |
| PSKIMLVEPPVAKVL | 286 | P18583 | |
| PPVFQMLLTKLPTIS | 116 | Q15388 | |
| IEKVMARSLSPPPEL | 531 | P49815 | |
| TPAPPLSMLRIKSEN | 391 | Q5T124 | |
| EEKTPMPPISSVLLA | 216 | O43264 | |
| KPILPTATVRLPEMS | 1611 | Q9NR99 | |
| TLAPKEALIPPAMTV | 1541 | E9PAV3 | |
| IPAKSPEKCRLDMIP | 1911 | Q9NZM1 | |
| MPKSEIPSPQSQLLE | 331 | Q9ULJ8 |